var title_f39_37_40528="Examination metacarpal malrotation";
var content_f39_37_40528=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F73269&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F73269&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Examination for malrotation of metacarpals",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 429px; height: 323px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The metacarpophalangeal and proximal interphalangeal joints are flexed to 90 degrees in this photograph of two normal hands. Axial lines drawn through the middle and distal phalanges of the 2nd through 5th digits are nearly parallel and converge near the wrist.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Kevin Burroughs, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_37_40528=[""].join("\n");
var outline_f39_37_40528=null;
var title_f39_37_40529="Iris scissors";
var content_f39_37_40529=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F62803&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F62803&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Iris scissors",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 381px; height: 346px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Removal of scar tissue at anterior colporrhaphy.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_37_40529=[""].join("\n");
var outline_f39_37_40529=null;
var title_f39_37_40530="Erosive lichen planus";
var content_f39_37_40530=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F60224&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F60224&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Vulvar erosive lichen planus",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 349px; height: 293px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Erythema and erosions on the vulvar labial mucosa in a patient with erosive lichen planus.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from Ridley, CM, Neill, SM (Eds), The Vulva, 2nd ed, Blackwell Science, Oxford 1999. Copyright &copy; 1999 Blackwell Science.",
"    </div>",
"    <div class=\"contractual\">",
"     <br/>",
"     <a href=\"file://www.blackwell-science.com\">",
"      file://www.blackwell-science.com",
"     </a>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_37_40530=[""].join("\n");
var outline_f39_37_40530=null;
var title_f39_37_40531="Sulfacetamide (topical): Patient drug information";
var content_f39_37_40531=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Sulfacetamide (topical): Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?25/42/26276?source=see_link\">",
"     see \"Sulfacetamide (topical): Drug information\"",
"    </a>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?37/16/38147?source=see_link\">",
"     see \"Sulfacetamide (topical): Pediatric drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F9523091\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Klaron&reg;;",
"     </li>",
"     <li>",
"      Ovace&reg;;",
"     </li>",
"     <li>",
"      Ovace&reg; Plus",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F9523092\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Sulfacet-R",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10024610\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat bacterial infections.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691693",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat pimples (acne).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2692187",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat skin irritation and dandruff.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10024609\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2702966",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to sulfacetamide sodium or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701385",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have a sulfa (sulfonamide) allergy, talk with your doctor.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10024614\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10024615\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698344",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Skin irritation.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10024617\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699049",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad skin irritation.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10024612\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694772",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take this drug by mouth. Use on your skin only. Keep out of your mouth, nose, and eyes (may burn).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696257",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Wash your hands before and after use.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694623",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Clean affected part before use. Make sure to dry well.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10024613\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696441",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Put on a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10024618\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10024619\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 12307 Version 34.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0503-200.131.240.2-23F828356C-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_37_40531=[""].join("\n");
var outline_f39_37_40531=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9523091\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9523092\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024610\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024609\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024614\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024615\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024617\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024612\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024613\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024618\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024619\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?31/61/32723?source=related_link\">",
"      Sulfacetamide (ophthalmic): Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?17/55/18292?source=related_link\">",
"      Sulfacetamide (ophthalmic): Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?18/13/18643?source=related_link\">",
"      Sulfacetamide (ophthalmic): Pediatric drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?25/42/26276?source=related_link\">",
"      Sulfacetamide (topical): Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?37/16/38147?source=related_link\">",
"      Sulfacetamide (topical): Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f39_37_40532="Chlorzoxazone: Drug information";
var content_f39_37_40532=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Chlorzoxazone: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"mobipreview.htm?8/23/8564?source=see_link\">",
"    see \"Chlorzoxazone: Patient drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?4/19/4404?source=see_link\">",
"    see \"Chlorzoxazone: Pediatric drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F150751\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Lorzone&trade;;",
"     </li>",
"     <li>",
"      Parafon Forte&reg; DSC",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F150774\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Skeletal Muscle Relaxant",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F150754\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Muscle spasm:",
"     </b>",
"     Oral: 500 mg 3-4 times daily, may increase up to 750 mg 3-4 times daily. May consider dose reductions as symptoms improve.",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F150755\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     In general, avoid use or use cautiously at lower doses. Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block dor drugH1Div\" id=\"F15682618\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Renal Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No dosage adjustment provided in manufacturer&rsquo;s labeling.",
"    </p>",
"   </div>",
"   <div class=\"block doh drugH1Div\" id=\"F15682619\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Hepatic Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No dosage adjustment provided in manufacturer&rsquo;s labeling.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F150735\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Caplet, oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Parafon Forte&reg; DSC: 500 mg [scored]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Tablet, oral: 500 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Lorzone&trade;: 375 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Lorzone&trade;: 750 mg [scored]",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F150722\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F16250298\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Administer with or without food.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F150737\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Symptomatic treatment of muscle spasm and pain associated with acute musculoskeletal conditions",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F150780\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      BEERS Criteria medication:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       This drug may be potentially inappropriate for use in geriatric patients (Quality of evidence - moderate; Strength of recommendation - strong).",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F150772\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Frequency not defined.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Central nervous system: Dizziness, drowsiness, lightheadedness, paradoxical stimulation, malaise",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Dermatologic: Rash (rare), petechiae (rare), ecchymoses (rare), angioedema (very rare)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Gastrointestinal: Diarrhea, GI bleeding (rare), nausea, vomiting",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Genitourinary: Urine discoloration",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Hepatic: Liver dysfunction",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Miscellaneous: Anaphylaxis (very rare)",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F150740\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to chlorzoxazone or any component of the formulation",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F9954557\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      <i>",
"       Concerns related to adverse effects:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; CNS effects: May cause drowsiness, dizziness, or lightheadedness; effects may be potentiated by ethanol or other CNS depressants. Caution patients  about performing tasks which require mental alertness (eg, operating machinery or driving).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; Hepatotoxicity: Rare, serious (including fatal) idiosyncratic and unpredictable hepatocellular toxicity has been reported with use. Discontinue immediately if early signs/symptoms of hepatic toxicity arise (eg, fever, rash, anorexia, nausea, vomiting, fatigue, right upper quadrant pain, dark urine, jaundice). Also discontinue if elevated liver enzymes develop.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      <i>",
"       Special populations:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; Elderly: Muscle relaxants are poorly tolerated by the elderly due to potent anticholinergic effects, sedation, and risk of fracture. Efficacy is questionable at dosages tolerated by elderly patients; avoid use (Beers Criteria).",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F150769\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Substrate",
"     </b>",
"     of CYP1A2 (minor), CYP2A6 (minor), CYP2D6 (minor), CYP2E1 (minor), CYP3A4 (minor);",
"     <b>",
"      Note:",
"     </b>",
"     Assignment of Major/Minor substrate status based on clinically relevant drug interaction potential;",
"     <b>",
"      Inhibits",
"     </b>",
"     CYP2E1 (weak), CYP3A4 (weak)",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F150730\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Alcohol (Ethyl): CNS Depressants may enhance the CNS depressant effect of Alcohol (Ethyl).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     ARIPiprazole: CYP3A4 Inhibitors (Weak) may increase the serum concentration of ARIPiprazole.  Management: Monitor for increased aripiprazole pharmacologic effects. Aripiprazole dose adjustments may or may not be required based on concomitant therapy and/or indication. Consult full interaction monograph for specific recommendations.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Azelastine (Nasal): CNS Depressants may enhance the CNS depressant effect of Azelastine (Nasal).",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Buprenorphine: CNS Depressants may enhance the CNS depressant effect of Buprenorphine.  Management: Consider reduced doses of CNS depressants used in combination with buprenorphine.  Consider avoiding other CNS depressants in patients thought to be at high risk of buprenorphine overuse or self-injection.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CNS Depressants: May enhance the adverse/toxic effect of other CNS Depressants.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Levocabastine (Nasal).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Disulfiram: May decrease the metabolism of Chlorzoxazone.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Droperidol: May enhance the CNS depressant effect of CNS Depressants. Management: Consider dose reductions of droperidol or of other CNS agents (e.g., opioids, barbiturates) with concomitant use.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     HydrOXYzine: May enhance the CNS depressant effect of CNS Depressants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Isoniazid: May decrease the metabolism of Chlorzoxazone.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Lomitapide: CYP3A4 Inhibitors (Weak) may increase the serum concentration of Lomitapide.  Management: Limit the maximum adult dose of lomitapide to 30 mg daily when used in combination with any weak CYP3A4 inhibitor.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Magnesium Sulfate: May enhance the CNS depressant effect of CNS Depressants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Methotrimeprazine: CNS Depressants may enhance the CNS depressant effect of Methotrimeprazine. Methotrimeprazine may enhance the CNS depressant effect of CNS Depressants.  Management: Reduce adult dose of CNS depressant agents by 50% with initiation of concomitant methotrimeprazine therapy. Further CNS depressant dosage adjustments should be initiated only after clinically effective methotrimeprazine dose is established.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Metyrosine: CNS Depressants may enhance the sedative effect of Metyrosine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Mirtazapine: CNS Depressants may enhance the CNS depressant effect of Mirtazapine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Paraldehyde: CNS Depressants may enhance the CNS depressant effect of Paraldehyde.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Peginterferon Alfa-2b: May decrease the serum concentration of CYP2D6 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Perampanel: May enhance the CNS depressant effect of CNS Depressants. Management: Patients taking perampanel with any other drug that has CNS depressant activities should avoid complex and high-risk activities, particularly those such as driving that require alertness and coordination, until they have experience using the combination.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pimozide: CYP3A4 Inhibitors (Weak) may increase the serum concentration of Pimozide.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pramipexole: CNS Depressants may enhance the sedative effect of Pramipexole.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     ROPINIRole: CNS Depressants may enhance the sedative effect of ROPINIRole.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Rotigotine: CNS Depressants may enhance the sedative effect of Rotigotine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Selective Serotonin Reuptake Inhibitors: CNS Depressants may enhance the adverse/toxic effect of Selective Serotonin Reuptake Inhibitors. Specifically, the risk of psychomotor impairment may be enhanced.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Sodium Oxybate: May enhance the CNS depressant effect of CNS Depressants. Management: Consider alternatives to combined use. When combined use is needed, consider minimizing doses of one or more drugs. Use of sodium oxybate with alcohol or sedative hypnotics is contraindicated.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Zolpidem: CNS Depressants may enhance the CNS depressant effect of Zolpidem.  Management: Reduce the Intermezzo brand sublingual zolpidem dose to 1.75 mg for men who are also receiving other CNS depressants.  No such dose change is recommended for women.  Avoid use with other CNS depressants at bedtime; avoid use with alcohol.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block foi drugH1Div\" id=\"F150748\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Ethanol/Nutrition/Herb Interactions",
"    </span>",
"    <p style=\"text-indent:0em;margin-left:0em;text-align:justify;display:inline\">",
"     Ethanol: May increase CNS depression; monitor for increased effects with coadministration. Caution patients about effects.",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F13277400\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Animal reproduction studies have not been conducted.",
"    </p>",
"   </div>",
"   <div class=\"block lac drugH1Div\" id=\"F150758\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Lactation",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Excretion in breast milk unknown",
"    </p>",
"   </div>",
"   <div class=\"block fee drugH1Div\" id=\"F150741\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pricing: U.S. (Medi-Span&reg;)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tablets",
"     </b>",
"     (Chlorzoxazone Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     500 mg (500): $215.81",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tablets",
"     </b>",
"     (Lorzone Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     375 mg (100): $395.54",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     750 mg (100): $442.27",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tablets",
"     </b>",
"     (Parafon Forte DSC Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     500 mg (100): $351.56",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F150733\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Periodic liver functions tests",
"    </p>",
"   </div>",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F150742\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Escoflex (CH);",
"     </li>",
"     <li>",
"      Klorzoxazon (DK);",
"     </li>",
"     <li>",
"      Matalmin (TW);",
"     </li>",
"     <li>",
"      Muscol (TW);",
"     </li>",
"     <li>",
"      Myoflex (HR);",
"     </li>",
"     <li>",
"      Myoflexin (HN, HU);",
"     </li>",
"     <li>",
"      Paraflex (HR, NO, SE, TR, ZA);",
"     </li>",
"     <li>",
"      Parafon DSC (IN);",
"     </li>",
"     <li>",
"      Parafon Forte (MX, TH);",
"     </li>",
"     <li>",
"      Prolax (TW);",
"     </li>",
"     <li>",
"      Reumophan (MX);",
"     </li>",
"     <li>",
"      Reumophan Alka (MX);",
"     </li>",
"     <li>",
"      Reumophan Vit (MX);",
"     </li>",
"     <li>",
"      Salalin (TW);",
"     </li>",
"     <li>",
"      Sola (TW);",
"     </li>",
"     <li>",
"      Solaxin (HK, ID, JP);",
"     </li>",
"     <li>",
"      Tafirol Flex (MX)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F150725\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Acts on the spinal cord and subcortical areas of the brain to inhibit polysynaptic reflex arcs involved in causing and maintaining skeletal muscle spasms",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F150739\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Onset of action: ~1 hour",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Duration: Up to 6 hours (Desiraju, 1983)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Absorption: Readily absorbed",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Metabolism: Extensively hepatic via glucuronidation",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Half-life elimination: ~1 hour (Desiraju, 1983)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Time to peak: 1-2 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Excretion: Urine (predominately as conjugates; &lt;1% as unchanged drug)",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      American Geriatrics Society 2012 Beers Criteria Update Expert Panel, \"American Geriatrics Society Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults,\"",
"      <i>",
"       J Am Geriatr Soc",
"      </i>",
"      , 2012, 60(4):616-31.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?39/37/40532/abstract-text/22376048/pubmed\" id=\"22376048\" target=\"_blank\">",
"        22376048",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Desiraju RK, Renzi NL Jr, Nayak RK, et al, &ldquo;Pharmacokinetics of Chlorzoxazone in Humans,&rdquo;",
"      <i>",
"       J Pharm Sci",
"      </i>",
"      , 1983, 72(9):991-4.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?39/37/40532/abstract-text/6631711/pubmed\" id=\"6631711\" target=\"_blank\">",
"        6631711",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 9256 Version 43.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1003-190.111.122.2-0C8C6D5D65-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_37_40532=[""].join("\n");
var outline_f39_37_40532=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F150751\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F150774\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F150754\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F150755\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F15682618\">",
"      Dosing: Renal Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F15682619\">",
"      Dosing: Hepatic Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F150735\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F150722\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F16250298\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F150737\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F150780\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F150772\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F150740\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9954557\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F150769\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F150730\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F150748\">",
"      Ethanol/Nutrition/Herb Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13277400\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F150758\">",
"      Lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F150741\">",
"      Pricing: U.S. (Medi-Span&reg;)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F150733\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F150742\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F150725\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F150739\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9256\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9256|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?8/23/8564?source=related_link\">",
"      Chlorzoxazone: Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?4/19/4404?source=related_link\">",
"      Chlorzoxazone: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f39_37_40533="Menetriers disease Gross";
var content_f39_37_40533=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F63252&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F63252&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    M&eacute;n&eacute;trier's disease",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 367px; height: 230px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Surgical specimen from an adult with M&eacute;n&eacute;trier's disease. The body of the stomach is covered by thick knobby folds with a coarsely granular surface, the result of irregular pit hyperplasia.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     From: Lewin KJ, Appelman HD. Tumors of the esophagus and stomach. Atlas of tumor pathology (electronic fascicle), Third series, fascicle 18, 1996, Washington, DC. Armed Forces Institute of Pathology.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_37_40533=[""].join("\n");
var outline_f39_37_40533=null;
var title_f39_37_40534="Acetaminophen, diphenhydramine, and phenylephrine: Drug information";
var content_f39_37_40534=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Acetaminophen, diphenhydramine, and phenylephrine: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"mobipreview.htm?19/38/20069?source=see_link\">",
"    see \"Acetaminophen, diphenhydramine, and phenylephrine: Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F6816907\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Benadryl&reg; Allergy and Cold [OTC];",
"     </li>",
"     <li>",
"      Benadryl&reg; Allergy and Sinus Headache [OTC];",
"     </li>",
"     <li>",
"      Benadry&reg; Maximum Strength Severe Allergy and Sinus Headache [OTC];",
"     </li>",
"     <li>",
"      Cold Control PE [OTC];",
"     </li>",
"     <li>",
"      One Tab&trade; Allergy &amp; Sinus [OTC];",
"     </li>",
"     <li>",
"      One Tab&trade; Cold &amp; Flu [OTC];",
"     </li>",
"     <li>",
"      Robitussin&reg; Peak Cold Nighttime Multi-Symptom Cold [OTC];",
"     </li>",
"     <li>",
"      Sudafed PE&reg; Nighttime Cold [OTC];",
"     </li>",
"     <li>",
"      Sudafed PE&reg; Severe Cold [OTC];",
"     </li>",
"     <li>",
"      Theraflu&reg; Nighttime Severe Cold &amp; Cough [OTC];",
"     </li>",
"     <li>",
"      Theraflu&reg; Sugar-Free Nighttime Severe Cold &amp; Cough [OTC];",
"     </li>",
"     <li>",
"      Theraflu&reg; Warming Relief&trade; Flu &amp; Sore Throat [OTC];",
"     </li>",
"     <li>",
"      Theraflu&reg; Warming Relief&trade; Nighttime Severe Cold &amp; Cough [OTC];",
"     </li>",
"     <li>",
"      Tylenol&reg; Allergy Multi-Symptom Nighttime [OTC];",
"     </li>",
"     <li>",
"      Tylenol&reg; Children's Plus Cold and Allergy [OTC]",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F6816911\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Alpha-Adrenergic Agonist;",
"     </li>",
"     <li>",
"      Analgesic, Miscellaneous;",
"     </li>",
"     <li>",
"      Decongestant;",
"     </li>",
"     <li>",
"      Ethanolamine Derivative;",
"     </li>",
"     <li>",
"      Histamine H;",
"      <sub>",
"       1",
"      </sub>",
"      Antagonist",
"     </li>",
"     <li>",
"      Histamine H",
"      <sub>",
"       1",
"      </sub>",
"      Antagonist, First Generation",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F6816938\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Hay fever/cold symptoms:",
"     </b>",
"     Oral: General dosing guidelines; refer to specific product labeling:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Caplet (Benadryl&reg; Allergy and Cold, Benadryl&reg; Allergy and Sinus Headache, Sudafed PE&reg; Nighttime Cold, Sudafed PE&reg; Severe Cold, Tylenol&reg; Allergy Multi-Symptom Nighttime): Two caplets every 4 hours as needed; maximum: 12 caplets/24 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Powder for solution (Theraflu&reg; Nighttime Severe Cold &amp; Cough): One packet every 4 hours as needed; maximum: 6 doses/24 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Syrup (Theraflu&reg; Warming Relief&trade; Flu &amp; Sore Throat): 30 mL every 4 hours as needed; maximum: 6 doses/24 hours (180 mL/24 hours)",
"    </p>",
"   </div>",
"   <div class=\"block dop drugH1Div\" id=\"F6816937\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Pediatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Hay fever/cold symptoms:",
"     </b>",
"     Oral: General dosing guidelines; refer to specific product labeling:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Children 6-11 years (Benadryl&reg; Allergy and Cold, Benadryl&reg; Allergy and Sinus Headache, Sudafed PE&reg; Severe Cold): One caplet every 4 hours as needed; maximum: 5 caplets/24 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Children 6-11 years; 48-95 lbs (Tylenol&reg; Children&rsquo;s Plus Cold and Allergy): 10 mL every 4 hours as needed; maximum: 5 doses/24 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Children &ge;12 years: Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F6816939\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F6817447\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Caplet, oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Benadryl&reg; Allergy and Cold, Benadryl&reg; Allergy and Sinus Headache, Sudafed PE&reg; Severe Cold: Acetaminophen 325 mg, diphenhydramine hydrochloride 12.5 mg, and phenylephrine hydrochloride 5 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Benadry&reg; Maximum Strength Severe Allergy and Sinus Headache: Acetaminophen 325 mg, diphenhydramine hydrochloride 25 mg, and phenylephrine hydrochloride 5 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     One Tab&trade; Allergy &amp; Sinus: Acetaminophen 650 mg, diphenhydramine hydrochloride 25 mg, and phenylephrine hydrochloride 10 mg [dye free]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     One Tab&trade; Cold and Flu: Acetaminophen 650 mg, diphenhydramine hydrochloride 25 mg, and phenylephrine hydrochloride 10 mg [dye free]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Cold Control PE: Acetaminophen 650 mg, diphenhydramine hydrochloride 25 mg, and phenylephrine hydrochloride 10 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Sudafed PE&reg; Nighttime Cold: Acetaminophen 325 mg, diphenhydramine hydrochloride 25 mg, and phenylephrine hydrochloride 5 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Tylenol&reg; Allergy Multi-Symptom Nighttime: Acetaminophen 325 mg, diphenhydramine hydrochloride 25 mg, and phenylephrine hydrochloride 5 mg [Cool Burst&trade; flavor]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Liquid, oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Robitussin&reg; Peak Cold Nighttime Multi-Symptom Cold: Acetaminophen 160 mg, diphenhydramine hydrochloride 6.25 mg, and phenylephrine hydrochloride 2.5 mg per 5 mL (118 mL, 237 mL) [contains menthol, propylene glycol, sodium 4 mg/5 mL, sodium benzoate]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Tylenol&reg; Children's Plus Cold and Allergy: Acetaminophen 160 mg, diphenhydramine hydrochloride 12.5 mg, and phenylephrine hydrochloride 2.5 mg per 5 mL (120 mL) [contains sodium benzoate; bubble gum flavor]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Powder for solution, oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Theraflu&reg; Nighttime Severe Cold &amp; Cough: Acetaminophen 650 mg, diphenhydramine hydrochloride 25 mg, and phenylephrine hydrochloride 10 mg per packet (6s) [contains phenylalanine 13 mg, potassium 10 mg, and sodium 23 mg per packet; honey lemon flavor]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Theraflu&reg; Sugar-Free Nighttime Severe Cold &amp; Cough: Acetaminophen 650 mg, diphenhydramine hydrochloride 25 mg, and phenylephrine hydrochloride 10 mg per packet (6s) [sugar free; contains phenylalanine 13 mg, potassium 10 mg, and sodium 23 mg per packet; honey lemon flavor]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Syrup, oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Theraflu&reg; Warming Relief&trade; Flu &amp; Sore Throat: Acetaminophen 325 mg, diphenhydramine hydrochloride 12.5 mg, and phenylephrine hydrochloride 5 mg per 15 mL (245.5 mL) [contains ethanol, potassium 5 mg/15 mL, propylene glycol, sodium 5 mg/15 mL, sodium benzoate; cherry flavor]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Theraflu&reg; Warming Relief&trade; Nighttime Severe Cold &amp; Cough: Acetaminophen 325 mg, diphenhydramine hydrochloride 12.5 mg, and phenylephrine hydrochloride 5 mg per 15 mL (245.5 mL) [contains ethanol 10%, potassium 5 mg/15 mL, propylene glycol, sodium 5 mg/15 mL, sodium benzoate; cherry flavor]",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F6816909\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F6817445\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Administer without regard to meals.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Caplet (Tylenol&reg; Allergy Multi-Symptom Nighttime): Swallow whole; do not crush, chew, or dissolve.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Liquid (Tylenol&reg; Children&rsquo;s Plus Cold and Allergy):  Shake well before use. Only use enclosed dosing cup; do not use other devices.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Powder for solution (Theraflu&reg; Nighttime Severe Cold &amp; Cough): Dissolve contents of packet into 8 oz of hot water; sip while hot and consume within 10-15 minutes",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F6816912\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Temporary relief of symptoms of hay fever and the common cold, including sinus/nasal congestion and pain/pressure, headache, sneezing, runny nose, itchy/watery eyes, sore throat, fever, cough, and minor aches and pains",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F6816906\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Other safety concerns:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       Duplicate therapy issues: This product contains acetaminophen, which may be a component of combination products. Do not exceed the maximum recommended daily dose of acetaminophen.",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F6816919\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     See individual agents.",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F6816913\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Use with or within 14 days of MAO inhibitor therapy; concurrent use with other products containing acetaminophen, diphenhydramine (including topical) or phenylephrine",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F6816914\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concerns related to adverse effects:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; CNS depression: May cause CNS depression, which may impair physical or mental abilities; patients must be cautioned about performing tasks which require mental alertness (eg, operating machinery or driving).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Disease-related concerns:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Ethanol use: Use with caution in patients with alcoholic liver disease; consuming &ge;3 alcoholic drinks/day may increase the risk of liver damage.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hepatic impairment: Use caution in patients with hepatic impairment; acetaminophen may cause severe hepatic toxicity with acute overdose.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concurrent drug therapy issues:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Sedatives: Effects may be potentiated when used with other sedative drugs or ethanol.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Special populations:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Pediatrics: Use with caution in children; may cause excitability. Do not exceed pediatric dosing recommendations. If no recommendations exist on OTC labeling for patient&rsquo;s age, the product should",
"     <b>",
"      not",
"     </b>",
"     be administered without the guidance of a physician.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Other warnings/precautions:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Dosage limit: Limit acetaminophen dose to &lt;4 g/day (adults) or &lt;2.6 g/day (children &lt;12 years of age).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Self-medication (OTC use): Patients with hypertension, thyroid disease, diabetes mellitus, glaucoma, cardiovascular disease, or prostatic hyperplasia should consult healthcare provider prior to use. Patients with chronic cough (associated with COPD or smoking) and/or productive cough (eg, copious amounts of phlegm) should be evaluated by a healthcare provider prior to use. Products containing acetaminophen are not recommended in patients consuming &ge;3 alcoholic beverages/day; consult healthcare provider. If pain, nasal congestion, or cough increases in severity or persists &gt;7 days in adults (or &gt;5 days in children) during use, consult a physician. If redness, swelling, or rash occurs or if fever worsens or persists &gt;3 days during therapy, consult healthcare provider. If sore throat is severe, accompanied by fever, nausea/vomiting, headache, swelling or rash, or last &gt;2 days, discontinue use and consult healthcare provider. Discontinue use and contact healthcare provider if nervousness, dizziness, or sleeplessness occur.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13298666\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to individual components.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F6833066\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Acetylcholinesterase Inhibitors (Central): Anticholinergics may diminish the therapeutic effect of Acetylcholinesterase Inhibitors (Central). Acetylcholinesterase Inhibitors (Central) may diminish the therapeutic effect of Anticholinergics. If the anticholinergic action is a side effect of the agent, the result may be beneficial.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Aclidinium: May enhance the anticholinergic effect of Anticholinergics.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Alcohol (Ethyl): CNS Depressants may enhance the CNS depressant effect of Alcohol (Ethyl).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Amphetamines: May diminish the sedative effect of Antihistamines.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Anticholinergics: May enhance the adverse/toxic effect of other Anticholinergics.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Levocabastine (Nasal).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     ARIPiprazole: CYP2D6 Inhibitors (Moderate) may increase the serum concentration of ARIPiprazole.  Management: Monitor for increased aripiprazole pharmacologic effects. Aripiprazole dose adjustments may or may not be required based on concomitant therapy and/or indication. Consult full interaction monograph for specific recommendations.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Azelastine (Nasal): CNS Depressants may enhance the CNS depressant effect of Azelastine (Nasal).",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Benzylpenicilloyl Polylysine: Antihistamines may diminish the diagnostic effect of Benzylpenicilloyl Polylysine.  Management: Suspend systemic H1 antagonists for benzylpenicilloyl-polylysine skin testing and delay testing until systemic antihistaminic effects have dissipated. A histamine skin test may be used to assess persistent antihistaminic effects.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Betahistine: Antihistamines may diminish the therapeutic effect of Betahistine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Buprenorphine: CNS Depressants may enhance the CNS depressant effect of Buprenorphine.  Management: Consider reduced doses of CNS depressants used in combination with buprenorphine.  Consider avoiding other CNS depressants in patients thought to be at high risk of buprenorphine overuse or self-injection.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CNS Depressants: May enhance the adverse/toxic effect of other CNS Depressants.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Levocabastine (Nasal).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Codeine: CYP2D6 Inhibitors (Moderate) may diminish the therapeutic effect of Codeine. These CYP2D6 inhibitors may prevent the metabolic conversion of codeine to its active metabolite morphine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP2D6 Substrates: CYP2D6 Inhibitors (Moderate) may decrease the metabolism of CYP2D6 Substrates.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Tamoxifen.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Droperidol: May enhance the CNS depressant effect of CNS Depressants. Management: Consider dose reductions of droperidol or of other CNS agents (e.g., opioids, barbiturates) with concomitant use.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Fesoterodine: CYP2D6 Inhibitors may increase serum concentrations of the active metabolite(s) of Fesoterodine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Highest Risk QTc-Prolonging Agents: QTc-Prolonging Agents (Indeterminate Risk and Risk Modifying) may enhance the QTc-prolonging effect of Highest Risk QTc-Prolonging Agents.  Management: Avoid such combinations when possible.  Use should be accompanied by close monitoring for evidence of QT prolongation or other alterations of cardiac rhythm.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Hyaluronidase: Antihistamines may diminish the therapeutic effect of Hyaluronidase.  Management: Patients receiving antihistamines (particularly at larger doses) may not experience the desired clinical response to standard doses of hyaluronidase.  Larger doses of hyaluronidase may be required.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     HydrOXYzine: May enhance the CNS depressant effect of CNS Depressants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ipratropium (Oral Inhalation): May enhance the anticholinergic effect of Anticholinergics.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Magnesium Sulfate: May enhance the CNS depressant effect of CNS Depressants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Methotrimeprazine: CNS Depressants may enhance the CNS depressant effect of Methotrimeprazine. Methotrimeprazine may enhance the CNS depressant effect of CNS Depressants.  Management: Reduce adult dose of CNS depressant agents by 50% with initiation of concomitant methotrimeprazine therapy. Further CNS depressant dosage adjustments should be initiated only after clinically effective methotrimeprazine dose is established.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Metoprolol: CYP2D6 Inhibitors may increase the serum concentration of Metoprolol.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Metyrosine: CNS Depressants may enhance the sedative effect of Metyrosine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Mifepristone: May enhance the QTc-prolonging effect of QTc-Prolonging Agents (Indeterminate Risk and Risk Modifying). Management: Though the drugs listed here have uncertain QT-prolonging effects, they all have some possible association with QT prolongation and should generally be avoided when possible.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Mirtazapine: CNS Depressants may enhance the CNS depressant effect of Mirtazapine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Moderate Risk QTc-Prolonging Agents: QTc-Prolonging Agents (Indeterminate Risk and Risk Modifying) may enhance the QTc-prolonging effect of Moderate Risk QTc-Prolonging Agents.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Nebivolol: CYP2D6 Inhibitors (Moderate) may increase the serum concentration of Nebivolol.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Paraldehyde: CNS Depressants may enhance the CNS depressant effect of Paraldehyde.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Perampanel: May enhance the CNS depressant effect of CNS Depressants. Management: Patients taking perampanel with any other drug that has CNS depressant activities should avoid complex and high-risk activities, particularly those such as driving that require alertness and coordination, until they have experience using the combination.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pramipexole: CNS Depressants may enhance the sedative effect of Pramipexole.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pramlintide: May enhance the anticholinergic effect of Anticholinergics. These effects are specific to the GI tract.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Propafenone: May increase the serum concentration of CYP2D6 Inhibitors (Moderate).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     ROPINIRole: CNS Depressants may enhance the sedative effect of ROPINIRole.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Rotigotine: CNS Depressants may enhance the sedative effect of Rotigotine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Selective Serotonin Reuptake Inhibitors: CNS Depressants may enhance the adverse/toxic effect of Selective Serotonin Reuptake Inhibitors. Specifically, the risk of psychomotor impairment may be enhanced.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Sodium Oxybate: May enhance the CNS depressant effect of CNS Depressants. Management: Consider alternatives to combined use. When combined use is needed, consider minimizing doses of one or more drugs. Use of sodium oxybate with alcohol or sedative hypnotics is contraindicated.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tamoxifen: CYP2D6 Inhibitors (Moderate) may decrease serum concentrations of the active metabolite(s) of Tamoxifen. Specifically, CYP2D6 inhibitors may decrease the metabolic formation of highly potent active metabolites.  Management: Consider alternatives with less of an inhibitory effect on CYP2D6 activity when possible.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Thioridazine: CYP2D6 Inhibitors may decrease the metabolism of Thioridazine.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tiotropium: Anticholinergics may enhance the anticholinergic effect of Tiotropium.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     TraMADol: CYP2D6 Inhibitors (Moderate) may diminish the therapeutic effect of TraMADol. These CYP2D6 inhibitors may prevent the metabolic conversion of tramadol to its active metabolite that accounts for much of its opioid-like effects.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Zolpidem: CNS Depressants may enhance the CNS depressant effect of Zolpidem.  Management: Reduce the Intermezzo brand sublingual zolpidem dose to 1.75 mg for men who are also receiving other CNS depressants.  No such dose change is recommended for women.  Avoid use with other CNS depressants at bedtime; avoid use with alcohol.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block foi drugH1Div\" id=\"F6816922\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Ethanol/Nutrition/Herb Interactions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     See individual agents.",
"    </p>",
"   </div>",
"   <div class=\"block dic drugH1Div\" id=\"F8097624\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dietary Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Take without regard to meals. Some products may contain phenylalanine, potassium, and/or sodium.",
"    </p>",
"   </div>",
"   <div class=\"block fee drugH1Div\" id=\"F16321865\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pricing: U.S. (Medi-Span&reg;)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Liquid",
"     </b>",
"     (Robitussin NT Cough/Cold/Flu Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     6.25-2.5-160 mg/5 mL (118 mL): $5.00",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Liquid",
"     </b>",
"     (Robitussin Peak Cold Multi-Sym Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     6.25-2.5-160 mg/5 mL (118 mL): $5.00",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Liquid",
"     </b>",
"     (Theraflu Warming Relief Flu Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     12.5-5-325 mg/15 mL (245.5 mL): $4.61",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Liquid",
"     </b>",
"     (Theraflu Warming Relief Night Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     12.5-5-325 mg/15 mL (245.5 mL): $4.39",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Liquid",
"     </b>",
"     (Theraflu Warming Relief Sinus Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     12.5-5-325 mg/15 mL (245.5 mL): $4.61",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Pack",
"     </b>",
"     (Theraflu Severe Cold/Cgh Night Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     25-10-650 mg (6): $4.61",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Suspension",
"     </b>",
"     (Tylenol Childrens Plus Cld/Alg Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     12.5-2.5-160 mg/5 mL (120 mL): $5.50",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tablets",
"     </b>",
"     (Benadryl Allergy/Sinus Headach Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     12.5-5-325 mg (24): $4.46",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tablets",
"     </b>",
"     (Benadryl Severe Allergy/Sinus Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     25-5-325 mg (20): $4.46",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tablets",
"     </b>",
"     (Sudafed PE Severe Cold Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     12.5-5-325 mg (12): $3.40",
"    </p>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F6816933\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Acetaminophen inhibits the synthesis of prostaglandins in the central nervous system and peripherally blocks pain impulse generation.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Diphenhydramine is an H",
"     <sub>",
"      1",
"     </sub>",
"     -receptor antagonist.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Phenylephrine causes vasoconstriction of the arterioles of the nasal mucosa.",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F6816923\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     See individual agents.",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Antlitz AM, Mead JA Jr, and Tolentino MA, &ldquo;Potentiation of Oral Anticoagulant Therapy by Acetaminophen,&rdquo;",
"      <i>",
"       Curr Ther Res Clin Exp",
"      </i>",
"      , 1968, 10(10):501-7.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?39/37/40534/abstract-text/4971464/pubmed\" id=\"4971464\" target=\"_blank\">",
"        4971464",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Bagheri H, Bernhard NB, and Montastruc JL, &ldquo;Potentiation of the Acenocoumarol Anticoagulant Effect by Acetaminophen,&rdquo;",
"      <i>",
"       Ann Pharmacother",
"      </i>",
"      , 1999, 33(4):506.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?39/37/40534/abstract-text/10332548/pubmed\" id=\"10332548\" target=\"_blank\">",
"        10332548",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Bartle WR and Blakely JA, &ldquo;Potentiation of Warfarin Anticoagulation by Acetaminophen,&rdquo;",
"      <i>",
"       JAMA",
"      </i>",
"      , 1991, 265(10):1260.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?39/37/40534/abstract-text/1995971/pubmed\" id=\"1995971\" target=\"_blank\">",
"        1995971",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Boeijinga JJ, Boerstra EE, Ris P, et al, &ldquo;Interaction Between Paracetamol and Coumarin Anticoagulants,&rdquo;",
"      <i>",
"       Lancet",
"      </i>",
"      , 1982, 1(8270):506.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?39/37/40534/abstract-text/6121161/pubmed\" id=\"6121161\" target=\"_blank\">",
"        6121161",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Gadisseur AP, Van Der Meer FJ, and Rosendaal FR, &ldquo;Sustained Intake of Paracetamol (Acetaminophen) During Oral Anticoagulant Therapy With Coumarins Does Not Cause Clinically Important INR Changes: A Randomized Double-Blind Clinical Trial,&rdquo;",
"      <i>",
"       J Thromb Haemost",
"      </i>",
"      , 2003, 1(4):714-7.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?39/37/40534/abstract-text/12871405/pubmed\" id=\"12871405\" target=\"_blank\">",
"        12871405",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Gebauer MG, Nyfort-Hansen K, Henschke PJ, et al, &ldquo;Warfarin and Acetaminophen Interaction,&rdquo;",
"      <i>",
"       Pharmacotherapy",
"      </i>",
"      , 2003, 23(1):109-12.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?39/37/40534/abstract-text/12523469/pubmed\" id=\"12523469\" target=\"_blank\">",
"        12523469",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Hylek EM, Heiman H, Skates SJ, et al, &ldquo;Acetaminophen and Other Risk Factors for Excessive Warfarin Anticoagulation,&rdquo;",
"      <i>",
"       JAMA",
"      </i>",
"      , 1998, 279(9):657-62.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?39/37/40534/abstract-text/9496982/pubmed\" id=\"9496982\" target=\"_blank\">",
"        9496982",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Kwan D, Bartle WR, and Walker SE, &ldquo;The Effects of Acute and Chronic Acetaminophen Dosing on the Pharmacodynamics and Pharmacokinetics of (R)- and (S)-Warfarin,&rdquo;",
"      <i>",
"       Clin Pharmacol Ther",
"      </i>",
"      , 1995, 57:212.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Rubin RN, Mentzer RL, and Budzynski AZ, \"Potentiation of Anticoagulant Effect of Warfarin by Acetaminophen (Tylenol&reg;),\"",
"      <i>",
"       Clin Res",
"      </i>",
"      , 1984, 32:698a.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      van den Bemt PM, Geven LM, Kuitert NA, et al, \"The Potential Interaction Between Oral Anticoagulants and Acetaminophen in Everyday Practice,\"",
"      <i>",
"       Pharm World Sci",
"      </i>",
"      , 2002, 24(5):201-4.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?39/37/40534/abstract-text/12426965/pubmed\" id=\"12426965\" target=\"_blank\">",
"        12426965",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 8617 Version 39.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1005-122.72.76.133-2959C7380A-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_37_40534=[""].join("\n");
var outline_f39_37_40534=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6816907\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6816911\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6816938\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6816937\">",
"      Dosing: Pediatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6816939\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6817447\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6816909\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6817445\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6816912\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6816906\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6816919\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6816913\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6816914\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13298666\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6833066\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6816922\">",
"      Ethanol/Nutrition/Herb Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F8097624\">",
"      Dietary Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F16321865\">",
"      Pricing: U.S. (Medi-Span&reg;)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6816933\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6816923\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/8617\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/8617|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?19/38/20069?source=related_link\">",
"      Acetaminophen, diphenhydramine, and phenylephrine: Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f39_37_40535="Diseases with eosinophilic involvement of specific organs";
var content_f39_37_40535=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Diseases with eosinophilic involvement of specific organs",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?39/37/40535/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?39/37/40535/contributors\">",
"     Peter F Weller, MD, FACP",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?39/37/40535/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?39/37/40535/contributors\">",
"     Donald H Mahoney, Jr, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?39/37/40535/contributors\">",
"     Bruce S Bochner, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?39/37/40535/contributors\">",
"     Deputy Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?39/37/40535/contributors\">",
"     Elinor L Baron, MD, DTMH",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?39/37/40535/contributors\">",
"     Jennifer S Tirnauer, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?39/37/40535/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Dec 18, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Tissue eosinophilia may be present with or without blood eosinophilia. Eosinophilic infiltration of specific organs may suggest particular diagnoses and allow a more focused diagnostic work-up.",
"   </p>",
"   <p>",
"    Diseases with eosinophilic involvement of specific organs will be reviewed here. The approach to the patient with eosinophilia is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?24/10/24745?source=see_link\">",
"     \"Approach to the patient with eosinophilia\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     DERMATOLOGIC DISEASE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Eosinophils participate in the inflammatory infiltrate in numerous dermatologic conditions:",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Eosinophilic panniculitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Eosinophilic panniculitis is characterized by a prominent eosinophil infiltration of subcutaneous fat [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/37/40535/abstract/1\">",
"     1",
"    </a>",
"    ]. Lesions often are nodular but may present as plaques or vesicles. This pathology is commonly associated with gnathostomiasis, leukocytoclastic vasculitis, and erythema nodosum [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/37/40535/abstract/1-3\">",
"     1-3",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Episodic angioedema with eosinophilia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although blood eosinophilia does not usually accompany angioedema, the entity of episodic angioedema with eosinophilia (Gleich syndrome) is characterized by recurrent episodes of angioedema, urticaria, pruritus, fever, weight gain, elevated serum IgM, and leukocytosis with marked blood eosinophilia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/37/40535/abstract/4-7\">",
"     4-7",
"    </a>",
"    ]. The level of blood eosinophilia parallels disease activity.",
"   </p>",
"   <p>",
"    The etiology of this syndrome is unknown but has been associated with upregulation of C5a receptors on eosinophils during episodes of disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/37/40535/abstract/8\">",
"     8",
"    </a>",
"    ]. Patients respond to glucocorticoids and have an excellent long-term prognosis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Kimura disease and angiolymphoid hyperplasia with eosinophilia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Kimura disease presents as large subcutaneous masses on the head or neck of East Asian males, whereas angiolymphoid hyperplasia with eosinophilia occurs in all races and is characterized by generally smaller and more superficial lesions. Eosinophilia is common to both conditions, which are of unknown origin [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/37/40535/abstract/9-11\">",
"     9-11",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    One report described a series of 21 cases of Kimura disease in the United States, the majority of whom had eosinophilia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/37/40535/abstract/11\">",
"     11",
"    </a>",
"    ]. The posterior auricular or cervical lymph nodes were most often involved. Consistent histologic features included follicular hyperplasia, eosinophilic infiltrates and proliferation of postcapillary venules.",
"   </p>",
"   <p>",
"    Treatment usually consists of surgical resection. In addition, some case reports suggest a beneficial effect from corticosteroids, the selective H1 receptor antagonist",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?35/34/36390?source=see_link\">",
"     cetirizine",
"    </a>",
"    &nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/37/40535/abstract/12\">",
"     12",
"    </a>",
"    ] or radiotherapy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/37/40535/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Eosinophilic fasciitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Eosinophilic fasciitis, also known as Shulman's syndrome, is characterized by the acute onset of erythema, swelling, induration of the extremities, and eosinophilia, often following antecedent exercise. Unlike scleroderma, the epidermis and dermis are normal in Shulman's syndrome, with most pathology located in the subcutaneous tissue, fascia, and muscle. Fibrous septae of the subcutaneous fat are sclerotic, and there is a perivascular inflammatory infiltration of lymphocytes, plasma cell, histiocytes. Tissue eosinophils are increased in one-half to two-thirds of patients. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?8/10/8360?source=see_link\">",
"     \"Eosinophilic fasciitis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Eosinophilic cellulitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Eosinophilic cellulitis, also known as Wells' syndrome, is marked by recurrent lesions on the extremities; blood eosinophilia is present in 50 percent of cases (",
"    <a class=\"graphic graphic_picture graphicRef87394 \" href=\"mobipreview.htm?13/50/14114\">",
"     picture 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/37/40535/abstract/14,15\">",
"     14,15",
"    </a>",
"    ]. There are several different clinical variants [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/37/40535/abstract/15\">",
"     15",
"    </a>",
"    ]. Involved skin appears cellulitic but is not tender or warm; the diagnosis may be suspected when patients do not respond to appropriate antibiotic treatment for bacterial cellulitis. Histology of a lesion in the acute stage shows edematous dermis infiltrated by eosinophils in a perivascular pattern. In the chronic stage, distinctive \"flame figures\" composed of masses of collagen and intact and degranulated eosinophils may be seen [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/37/40535/abstract/16\">",
"     16",
"    </a>",
"    ]. The skin findings usually resolve in two to eight weeks. Wells' syndrome may be idiopathic, drug-related, or associated with myeloproliferative, immunologic, or infectious disorders [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/37/40535/abstract/17\">",
"     17",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Eosinophilic pustular folliculitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Mixed eosinophilic and neutrophilic infiltrates in hair follicles with or without blood eosinophilia occur in eosinophilic pustular folliculitis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/37/40535/abstract/18\">",
"     18",
"    </a>",
"    ]. It is found primarily in HIV-positive patients, patients undergoing treatment for hematologic malignancies, and bone marrow transplant recipients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/37/40535/abstract/19\">",
"     19",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?23/50/24359?source=see_link\">",
"     \"HIV-associated eosinophilic folliculitis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Recurrent cutaneous necrotizing eosinophilic vasculitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;In this distinct vasculitis of small dermal vessels, skin biopsies show necrotizing vasculitis with minimal or absent leukocytoclasis and an almost exclusive eosinophilic infiltration in vessel walls and lumen [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/37/40535/abstract/20\">",
"     20",
"    </a>",
"    ]. Patients usually respond to systemic glucocorticoid treatment and pursue a chronic but relatively benign course.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Eosinophilic ulcers of the oral mucosa",
"    </span>",
"    &nbsp;&mdash;&nbsp;These ulcerated lesions appear to result from trauma, are usually tender and multiple, and often involve the tongue. Eosinophilic infiltration is prominent, and the lesions usually heal spontaneously over several weeks [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/37/40535/abstract/21\">",
"     21",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Other dermatologic conditions",
"    </span>",
"    &nbsp;&mdash;&nbsp;Blood and tissue eosinophilia are common in atopic dermatitis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/37/40535/abstract/22,23\">",
"     22,23",
"    </a>",
"    ], and tissue eosinophils may be seen in blistering diseases such as bullous pemphigoid, pemphigus vulgaris, dermatitis herpetiformis, and herpes gestationis. Eosinophils or deposited eosinophil granule proteins can also be prominent in drug-induced lesions, chronic urticaria, solar urticaria, delayed pressure urticaria [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/37/40535/abstract/24\">",
"     24",
"    </a>",
"    ], the pregnancy-related dermatosis, pruritic urticarial papules and plaques syndrome, and in orbital pseudotumors [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/37/40535/abstract/25\">",
"     25",
"    </a>",
"    ]. An uncommon disorder, characterized by the association of nodules, eosinophilia, rheumatism, dermatitis, and swelling (NERDS), includes prominent para-articular nodules, recurrent urticaria with angioedema, and tissue and blood eosinophilia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/37/40535/abstract/26\">",
"     26",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     PULMONARY DISEASE",
"    </span>",
"    &nbsp;&mdash;&nbsp;A variety of pulmonary diseases can be associated with eosinophilic inflammation of the airways, lung parenchyma, or pleura.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Airway disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Eosinophilic infiltration of bronchial mucosa is a typical finding in asthma; eosinophils are often seen in expectorated sputum, particularly during flares of asthma. Airway hyperresponsiveness is a characteristic feature of asthma. When this is absent, airway eosinophilia may be due to non-asthmatic eosinophilic bronchitis. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?19/1/19482?source=see_link\">",
"     \"Diagnosis of asthma in adolescents and adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?5/18/5418?source=see_link&amp;anchor=H13#H13\">",
"     \"Evaluation of subacute and chronic cough in adults\", section on 'Nonasthmatic eosinophilic bronchitis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Parenchymal disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Abnormally high numbers of eosinophils may be seen in the pulmonary parenchyma in many conditions. These include parasitic infections, drug reactions, allergic bronchopulmonary aspergillosis, acute and chronic eosinophilic pneumonias, the hypereosinophilic syndrome, and Churg-Strauss syndrome. Less commonly, pulmonary eosinophilia occurs in association with bronchiolitis obliterans organizing pneumonia, rheumatoid arthritis, Sj&ouml;gren's syndrome, malignancy, eosinophilic granuloma, post-radiation therapy, graft-versus-host disease, and systemic sclerosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/37/40535/abstract/27\">",
"     27",
"    </a>",
"    ]. Coccidioidal infection is in the differential diagnosis of eosinophilic pneumonia because organisms may be absent from cultures and open lung biopsy specimens [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/37/40535/abstract/28\">",
"     28",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?27/2/27688?source=see_link\">",
"     \"Causes of pulmonary eosinophilia\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Bronchoalveolar lavage (BAL) eosinophilia (&gt;5 percent of differential count) is seen in approximately 5 percent of bronchoscopies and is often unaccompanied by blood eosinophilia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/37/40535/abstract/29,30\">",
"     29,30",
"    </a>",
"    ]. One series of 48 patients with BAL eosinophilia found that the most common associated conditions were interstitial lung disease (eg, idiopathic pulmonary fibrosis, sarcoidosis, systemic lupus erythematosus, and hypersensitivity pneumonitis) (40 percent), AIDS-related pneumonia (17 percent), idiopathic eosinophilic pneumonia (15 percent) and drug-induced lung disease (12 percent) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/37/40535/abstract/29\">",
"     29",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Pleural disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pleural fluid eosinophilia is commonly associated with air or blood in the pleural space and usually has a benign, self&ndash;limited course [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/37/40535/abstract/31\">",
"     31",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?28/53/29527?source=see_link\">",
"     \"Pleural fluid eosinophilia\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     GASTROINTESTINAL DISEASE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Tissue eosinophilia develops with a number of gastrointestinal and hepatobiliary disorders. Blood eosinophilia is present less frequently. Gastrointestinal eosinophilia elicited by intestinal parasites or by a hypersensitivity reaction to medications must be excluded in patients with the following eosinophilic conditions.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Eosinophilic gastroenteritis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Eosinophilic gastroenteritis is an uncommon disorder characterized by gastrointestinal symptoms, blood eosinophilia, and eosinophilic infiltration of the gastrointestinal wall; peak onset is in the third decade of life [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/37/40535/abstract/32\">",
"     32",
"    </a>",
"    ]. Although allergies to foods or milk contribute to this disease in some children, allergic etiologies are not common in adults.",
"   </p>",
"   <p>",
"    Different layers of the bowel may be involved [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/37/40535/abstract/32,33\">",
"     32,33",
"    </a>",
"    ]. Mucosal involvement alone may result in abdominal pain, nausea, vomiting, diarrhea, weight loss, anemia, protein-losing enteropathy, and intestinal perforation. Patients with muscular layer involvement have symptoms of pyloric or intestinal obstruction and early satiety while subserosal eosinophilic infiltration may result in development of eosinophilic ascites. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?42/43/43703?source=see_link\">",
"     \"Eosinophilic gastroenteritis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Eosinophilic esophagitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Eosinophilic esophagitis is a disorder, presumably of allergic etiology, associated with dense esophageal eosinophilia. Adults typically present with dysphagia",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    food impaction while children have a more variable presentation depending in part upon their age. Patients often have a history of allergies and laboratories may demonstrate a peripheral eosinophilia. Strictures may be seen on endoscopy; histopathology reveals a dense mucosal infiltration with eosinophils. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?31/45/32474?source=see_link\">",
"     \"Pathogenesis, clinical manifestations, and diagnosis of eosinophilic esophagitis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Hepatobiliary diseases",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hepatic eosinophilia develops in response to some medications (see above) and to helminthic parasites. Schistosomes (whose eggs embolize into the portal system and elicit eosinophil-enriched granulomas and fibrosis), migrating larvae (eg, visceral larva migrans), and hepatobiliary parasites (eg, Clonorchis) may all lead to hepatic eosinophilia. Other etiologies include primary biliary cirrhosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/37/40535/abstract/34\">",
"     34",
"    </a>",
"    ], hypereosinophilic syndrome [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/37/40535/abstract/35,36\">",
"     35,36",
"    </a>",
"    ], sclerosing cholangitis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/37/40535/abstract/37\">",
"     37",
"    </a>",
"    ], eosinophilic cholangitis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/37/40535/abstract/38\">",
"     38",
"    </a>",
"    ], and eosinophilic cholecystitis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/37/40535/abstract/39\">",
"     39",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Other gastrointestinal diseases",
"    </span>",
"    &nbsp;&mdash;&nbsp;Local tissue infiltration may be noted in patients with gastroesophageal acid reflux disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/37/40535/abstract/40,41\">",
"     40,41",
"    </a>",
"    ], Helicobacter pylori infection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/37/40535/abstract/42\">",
"     42",
"    </a>",
"    ], inflammatory bowel disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/37/40535/abstract/43\">",
"     43",
"    </a>",
"    ], celiac disease, and collagenous colitis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/37/40535/abstract/44\">",
"     44",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h1\">",
"     CARDIAC DISEASE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Endomyocardial fibrosis and intraventricular thrombosis may occur following a variety of eosinophilic syndromes including hypersensitivity myocarditis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/37/40535/abstract/45\">",
"     45",
"    </a>",
"    ], parasitic infections [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/37/40535/abstract/35,46\">",
"     35,46",
"    </a>",
"    ], hypereosinophilic syndrome [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/37/40535/abstract/35,46\">",
"     35,46",
"    </a>",
"    ], eosinophilic leukemia, sarcomas, carcinomas, lymphomas [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/37/40535/abstract/47\">",
"     47",
"    </a>",
"    ], GM-CSF administration [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/37/40535/abstract/48\">",
"     48",
"    </a>",
"    ], and prolonged drug-induced eosinophilia. Eosinophilic coronary arteritis occurs secondary to Churg-Strauss syndrome.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h1\">",
"     RENAL DISEASE",
"    </span>",
"    &nbsp;&mdash;&nbsp;A number of conditions can result either in eosinophiluria or eosinophilic infiltration of the kidneys or urinary tract.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h2\">",
"     Eosinophiluria",
"    </span>",
"    &nbsp;&mdash;&nbsp;Eosinophiluria may be found in patients with drug-induced acute interstitial nephritis, rapidly progressive and acute poststreptococcal glomerulonephritis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/37/40535/abstract/49\">",
"     49",
"    </a>",
"    ], eosinophilic prostatitis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/37/40535/abstract/50\">",
"     50",
"    </a>",
"    ], eosinophilic cystitis, renal transplant rejection, bladder cancer [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/37/40535/abstract/51\">",
"     51",
"    </a>",
"    ], cholesterol embolization, and schistosomiasis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/37/40535/abstract/52,53\">",
"     52,53",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?33/39/34418?source=see_link\">",
"     \"The significance of urinary eosinophils\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h2\">",
"     Eosinophilic cystitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Eosinophilic cystitis presents with hematuria, urinary frequency, dysuria, and suprapubic pain. It occurs more often in children than adults and is of unknown etiology. Cystoscopy reveals diffusely hyperemic mucosa with nodular areas of prominent eosinophilic infiltration, numerous IgA or IgE plasma cells, mucosal edema, and muscle necrosis. Subsequently, chronic inflammation and fibrosis of the mucosa and muscularis develop.",
"   </p>",
"   <p>",
"    The diagnosis is confirmed histologically; bladder carcinoma is the principal alternative diagnosis. Although most patients have a benign course with spontaneous resolution, some chronic cases progress to bladder destruction and renal failure [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/37/40535/abstract/54\">",
"     54",
"    </a>",
"    ]. A variety of treatments can be considered including fulguration, analgesics, or corticosteroids [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/37/40535/abstract/55\">",
"     55",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h2\">",
"     Other",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients on hemodialysis may have mild eosinophilia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/37/40535/abstract/56\">",
"     56",
"    </a>",
"    ], and initiation of peritoneal dialysis leads to usually self-limited episodes of peritoneal eosinophilia with or without blood eosinophilia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/37/40535/abstract/57\">",
"     57",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h1\">",
"     NEUROLOGIC DISEASE",
"    </span>",
"    &nbsp;&mdash;&nbsp;The combination of neurologic findings and eosinophilia may be seen in the hypereosinophilic syndrome, Churg-Strauss vasculitis, and with eosinophilic meningitis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h1\">",
"     CHRONIC SINUSITIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Eosinophilia of involved tissues is frequent in chronic sinusitis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/37/40535/abstract/58\">",
"     58",
"    </a>",
"    ]. In adults, blood eosinophilia indicates a high likelihood of extensive disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/37/40535/abstract/58\">",
"     58",
"    </a>",
"    ]. Allergic fungal sinusitis is associated with lesional and nasal eosinophilia. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?8/36/8775?source=see_link\">",
"     \"Fungal rhinosinusitis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h1\">",
"     OTHER CAUSES OF SOLID ORGAN EOSINOPHILIC DISEASE",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29\">",
"    <span class=\"h2\">",
"     Transplant rejection",
"    </span>",
"    &nbsp;&mdash;&nbsp;Infiltration of eosinophils may accompany rejection of transplanted kidneys, and blood and urinary eosinophil counts have been monitored as indicators of rejection. Portal tract infiltrate on a liver biopsy in a transplant patient has been stressed by some investigators as a warning sign of rejection (see",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?12/13/12505?source=see_link\">",
"     \"Clinical manifestations and diagnosis of acute renal allograft rejection\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?36/28/37319?source=see_link\">",
"     \"Diagnosis of acute cellular rejection in liver transplantation\"",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30\">",
"    <span class=\"h2\">",
"     Irritation of serosal surfaces",
"    </span>",
"    &nbsp;&mdash;&nbsp;Mechanical, chemical, or radiation-induced irritation of the pleura, pericardium, or peritoneum may produce local or blood eosinophilia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/37/40535/abstract/59\">",
"     59",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H31\">",
"    <span class=\"h2\">",
"     Hereditary eosinophilia",
"    </span>",
"    &nbsp;&mdash;&nbsp;A kindred with hereditary (or familial) eosinophilia has been reported [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/37/40535/abstract/60\">",
"     60",
"    </a>",
"    ]. The pathogenesis of this condition is uncertain. One study suggests that patients with this disorder can be distinguished from those with hypereosinophilic syndromes (HES) by the relative absence of markers of eosinophil activation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/37/40535/abstract/61\">",
"     61",
"    </a>",
"    ]. The course of familial eosinophilia appears to be more benign than HES. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?29/24/30090?source=see_link\">",
"     \"Clinical manifestations, pathophysiology, and diagnosis of the hypereosinophilic syndromes\"",
"    </a>",
"    .)",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/37/40535/abstract/1\">",
"      Adame J, Cohen PR. Eosinophilic panniculitis: diagnostic considerations and evaluation. J Am Acad Dermatol 1996; 34:229.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/37/40535/abstract/2\">",
"      Glass LA, Zaghloul AB, Solomon AR. Eosinophilic panniculitis associated with chronic recurrent parotitis. Am J Dermatopathol 1989; 11:555.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/37/40535/abstract/3\">",
"      Kato N. Eosinophilic panniculitis. J Dermatol 1993; 20:185.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/37/40535/abstract/4\">",
"      Gleich GJ, Schroeter AL, Marcoux JP, et al. Episodic angioedema associated with eosinophilia. N Engl J Med 1984; 310:1621.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/37/40535/abstract/5\">",
"      Lassalle P, Gosset P, Gruart V, et al. Presence of antibodies against endothelial cells in the sera of patients with episodic angioedema and hypereosinophilia. Clin Exp Immunol 1990; 82:38.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/37/40535/abstract/6\">",
"      Bain BJ, Fletcher SH. Chronic eosinophilic leukemias and the myeloproliferative variant of the hypereosinophilic syndrome. Immunol Allergy Clin North Am 2007; 27:377.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/37/40535/abstract/7\">",
"      Florian S, Esterbauer H, Binder T, et al. Systemic mastocytosis (SM) associated with chronic eosinophilic leukemia (SM-CEL): detection of FIP1L1/PDGFRalpha, classification by WHO criteria, and response to therapy with imatinib. Leuk Res 2006; 30:1201.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/37/40535/abstract/8\">",
"      Nakashima K, Sakurada T, Imayama S, et al. A case of episodic angioedema associated with blood eosinophilia: upregulated C5a receptor expression on eosinophils. Allergy 1998; 53:320.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/37/40535/abstract/9\">",
"      Don DM, Ishiyama A, Johnstone AK, et al. Angiolymphoid hyperplasia with eosinophilia and vascular tumors of the head and neck. Am J Otolaryngol 1996; 17:240.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/37/40535/abstract/10\">",
"      Helander SD, Peters MS, Kuo TT, Su WP. Kimura's disease and angiolymphoid hyperplasia with eosinophilia: new observations from immunohistochemical studies of lymphocyte markers, endothelial antigens, and granulocyte proteins. J Cutan Pathol 1995; 22:319.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/37/40535/abstract/11\">",
"      Chen H, Thompson LD, Aguilera NS, Abbondanzo SL. Kimura disease: a clinicopathologic study of 21 cases. Am J Surg Pathol 2004; 28:505.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/37/40535/abstract/12\">",
"      Ben-Chetrit E, Amir G, Shalit M. Cetirizine: An effective agent in Kimura's disease. Arthritis Rheum 2005; 53:117.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/37/40535/abstract/13\">",
"      Chang AR, Kim K, Kim HJ, et al. Outcomes of Kimura's disease after radiotherapy or nonradiotherapeutic treatment modalities. Int J Radiat Oncol Biol Phys 2006; 65:1233.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/37/40535/abstract/14\">",
"      Aberer W, Konrad K, Wolff K. Wells' syndrome is a distinctive disease entity and not a histologic diagnosis. J Am Acad Dermatol 1988; 18:105.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/37/40535/abstract/15\">",
"      Caputo R, Marzano AV, Vezzoli P, Lunardon L. Wells syndrome in adults and children: a report of 19 cases. Arch Dermatol 2006; 142:1157.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/37/40535/abstract/16\">",
"      Beer TW, Langtry JA, Phillips WG, Wojnarowska F. Flame figures in bullous pemphigoid. Dermatology 1994; 188:310.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/37/40535/abstract/17\">",
"      Falagas ME, Vergidis PI. Narrative review: diseases that masquerade as infectious cellulitis. Ann Intern Med 2005; 142:47.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/37/40535/abstract/18\">",
"      McCalmont TH, Altemus D, Maurer T, Berger TG. Eosinophilic folliculitis. The histologic spectrum. Am J Dermatopathol 1995; 17:439.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/37/40535/abstract/19\">",
"      Ota M, Shimizu T, Hashino S, Shimizu H. Eosinophilic folliculitis in a patient after allogeneic bone marrow transplantation: case report and review of the literature. Am J Hematol 2004; 76:295.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/37/40535/abstract/20\">",
"      Chen KR, Su WP, Pittelkow MR, Leiferman KM. Eosinophilic vasculitis syndrome: recurrent cutaneous eosinophilic necrotizing vasculitis. Semin Dermatol 1995; 14:106.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/37/40535/abstract/21\">",
"      el-Mofty SK, Swanson PE, Wick MR, Miller AS. Eosinophilic ulcer of the oral mucosa. Report of 38 new cases with immunohistochemical observations. Oral Surg Oral Med Oral Pathol 1993; 75:716.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/37/40535/abstract/22\">",
"      Uehara M, Izukura R, Sawai T. Blood eosinophilia in atopic dermatitis. Clin Exp Dermatol 1990; 15:264.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/37/40535/abstract/23\">",
"      Leiferman KM. Eosinophils in atopic dermatitis. J Allergy Clin Immunol 1994; 94:1310.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/37/40535/abstract/24\">",
"      McEvoy MT, Peterson EA, Kobza-Black A, et al. Immunohistological comparison of granulated cell proteins in induced immediate urticarial dermographism and delayed pressure urticaria lesions. Br J Dermatol 1995; 133:853.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/37/40535/abstract/25\">",
"      Noguchi H, Kephart GM, Campbell RJ, et al. Tissue eosinophilia and eosinophil degranulation in orbital pseudotumor. Ophthalmology 1991; 98:928.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/37/40535/abstract/26\">",
"      Zenarola P, Melillo L, Bisceglia M, et al. NERDS syndrome: an additional case report. Dermatology 1995; 191:133.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/37/40535/abstract/27\">",
"      Allen JN, Davis WB. Eosinophilic lung diseases. Am J Respir Crit Care Med 1994; 150:1423.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/37/40535/abstract/28\">",
"      Lombard CM, Tazelaar HD, Krasne DL. Pulmonary eosinophilia in coccidioidal infections. Chest 1987; 91:734.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/37/40535/abstract/29\">",
"      Allen JN, Davis WB, Pacht ER. Diagnostic significance of increased bronchoalveolar lavage fluid eosinophils. Am Rev Respir Dis 1990; 142:642.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/37/40535/abstract/30\">",
"      Fleury-Feith J, Van Nhieu JT, Picard C, et al. Bronchoalveolar lavage eosinophilia associated with Pneumocystis carinii pneumonitis in AIDS patients. Comparative study with non-AIDS patients. Chest 1989; 95:1198.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/37/40535/abstract/31\">",
"      Adelman M, Albelda SM, Gottlieb J, Haponik EF. Diagnostic utility of pleural fluid eosinophilia. Am J Med 1984; 77:915.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/37/40535/abstract/32\">",
"      Min KU, Metcalf DD. Eosinophilic gastroenteritis. Immunol Allergy Clin North Am 1991; 11:799.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/37/40535/abstract/33\">",
"      Talley NJ, Shorter RG, Phillips SF, Zinsmeister AR. Eosinophilic gastroenteritis: a clinicopathological study of patients with disease of the mucosa, muscle layer, and subserosal tissues. Gut 1990; 31:54.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/37/40535/abstract/34\">",
"      Yamazaki K, Nakadate I, Suzuki K, et al. Eosinophilia in primary biliary cirrhosis. Am J Gastroenterol 1996; 91:516.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/37/40535/abstract/35\">",
"      Weller PF, Bubley GJ. The idiopathic hypereosinophilic syndrome. Blood 1994; 83:2759.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/37/40535/abstract/36\">",
"      Dillon JF, Finlayson ND. Idiopathic hypereosinophilic syndrome presenting as intrahepatic cholestatic jaundice. Am J Gastroenterol 1994; 89:1254.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/37/40535/abstract/37\">",
"      Grauer, L, Padilla, VMd, Bouza, L, Barkin, JS. Eosinophilic sclerosing cholangitis associated with hypereosinophilic syndrome. Am J Gastroenterol 1993; 88:1764.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/37/40535/abstract/38\">",
"      Rosengart TK, Rotterdam H, Ranson JH. Eosinophilic cholangitis: a self-limited cause of extrahepatic biliary obstruction. Am J Gastroenterol 1990; 85:582.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/37/40535/abstract/39\">",
"      Dabbs DJ. Eosinophilic and lymphoeosinophilic cholecystitis. Am J Surg Pathol 1993; 17:497.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/37/40535/abstract/40\">",
"      Winter HS, Madara JL, Stafford RJ, et al. Intraepithelial eosinophils: a new diagnostic criterion for reflux esophagitis. Gastroenterology 1982; 83:818.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/37/40535/abstract/41\">",
"      Brown LF, Goldman H, Antonioli DA. Intraepithelial eosinophils in endoscopic biopsies of adults with reflux esophagitis. Am J Surg Pathol 1984; 8:899.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/37/40535/abstract/42\">",
"      Karttunen TJ, Niemel&auml; S, Kerola T. Blood leukocyte differential in Helicobacter pylori infection. Dig Dis Sci 1996; 41:1332.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/37/40535/abstract/43\">",
"      Bischoff SC, Wedemeyer J, Herrmann A, et al. Quantitative assessment of intestinal eosinophils and mast cells in inflammatory bowel disease. Histopathology 1996; 28:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/37/40535/abstract/44\">",
"      Ettinghausen SE. Collagenous colitis, eosinophilic colitis, and neutropenic colitis. Surg Clin North Am 1993; 73:993.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/37/40535/abstract/45\">",
"      Kendell KR, Day JD, Hruban RH, et al. Intimate association of eosinophils to collagen bundles in eosinophilic myocarditis and ranitidine-induced hypersensitivity myocarditis. Arch Pathol Lab Med 1995; 119:1154.",
"     </a>",
"    </li>",
"    <li>",
"     Spry CJF. A Comprehensive Review and Guide to the Scientific and Medical Literature, Oxford Medical Publications, Oxford 1988.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/37/40535/abstract/47\">",
"      Monsuez JJ, de Kerviler E, Barboteu M, et al. Non-Hodgkin's lymphoma related eosinophilic endomyocardial disease. Eur Heart J 1994; 15:1423.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/37/40535/abstract/48\">",
"      Donhuijsen K, Haedicke C, Hattenberger S, et al. Granulocyte-macrophage colony-stimulating factor-related eosinophilia and Loeffler's endocarditis. Blood 1992; 79:2798.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/37/40535/abstract/49\">",
"      Date A, Jacob M, Johny KV. Eosinophilic leukocytes in diffuse proliferative and exudative glomerulonephritis. Am J Trop Med Hyg 1977; 26:1028.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/37/40535/abstract/50\">",
"      Liu S, Miller PD, Holmes SA, et al. Eosinophilic prostatitis and prostatic specific antigen. Br J Urol 1992; 69:61.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/37/40535/abstract/51\">",
"      Lowe D, Fletcher CD, Gower RL. Tumour-associated eosinophilia in the bladder. J Clin Pathol 1984; 37:500.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/37/40535/abstract/52\">",
"      Nolan CR 3rd, Anger MS, Kelleher SP. Eosinophiluria--a new method of detection and definition of the clinical spectrum. N Engl J Med 1986; 315:1516.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/37/40535/abstract/53\">",
"      Eltoum IA, Ghalib HW, Sualaiman S, et al. Significance of eosinophiluria in urinary schistosomiasis. A study using Hansel's stain and electron microscopy. Am J Clin Pathol 1989; 92:329.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/37/40535/abstract/54\">",
"      Itano NM, Malek RS. Eosinophilic cystitis in adults. J Urol 2001; 165:805.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/37/40535/abstract/55\">",
"      Kili&ccedil; S, Erguvan R, Ipek D, et al. Eosinophilic cystitis. A rare inflammatory pathology mimicking bladder neoplasms. Urol Int 2003; 71:285.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/37/40535/abstract/56\">",
"      Lee CC, Leu ML, Kuo HP, Huang CC. Hypereosinophilia in hemodialysis patients. Changgeng Yi Xue Za Zhi 1995; 18:20.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/37/40535/abstract/57\">",
"      Chan MK, Chow L, Lam SS, Jones B. Peritoneal eosinophilia in patients on continuous ambulatory peritoneal dialysis: a prospective study. Am J Kidney Dis 1988; 11:180.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/37/40535/abstract/58\">",
"      Newman LJ, Platts-Mills TA, Phillips CD, et al. Chronic sinusitis. Relationship of computed tomographic findings to allergy, asthma, and eosinophilia. JAMA 1994; 271:363.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/37/40535/abstract/59\">",
"      Dalal BI, Das KC, Dutta TK, Malakar K. Local and systemic eosinophilia in patients with carcinoma of the uterine cervix undergoing radiation therapy: correlation with radiation response. Clin Oncol (R Coll Radiol) 1992; 4:18.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/37/40535/abstract/60\">",
"      Lin AY, Nutman TB, Kaslow D, et al. Familial eosinophilia: clinical and laboratory results on a U.S. kindred. Am J Med Genet 1998; 76:229.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/37/40535/abstract/61\">",
"      Klion AD, Law MA, Riemenschneider W, et al. Familial eosinophilia: a benign disorder? Blood 2004; 103:4050.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 5701 Version 5.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-190.102.30.19-A54EBD57DC-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_37_40535=[""].join("\n");
var outline_f39_37_40535=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      DERMATOLOGIC DISEASE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Eosinophilic panniculitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Episodic angioedema with eosinophilia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Kimura disease and angiolymphoid hyperplasia with eosinophilia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Eosinophilic fasciitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Eosinophilic cellulitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Eosinophilic pustular folliculitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Recurrent cutaneous necrotizing eosinophilic vasculitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Eosinophilic ulcers of the oral mucosa",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Other dermatologic conditions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      PULMONARY DISEASE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Airway disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Parenchymal disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Pleural disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      GASTROINTESTINAL DISEASE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Eosinophilic gastroenteritis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Eosinophilic esophagitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Hepatobiliary diseases",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Other gastrointestinal diseases",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      CARDIAC DISEASE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      RENAL DISEASE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      Eosinophiluria",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      Eosinophilic cystitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      Other",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      NEUROLOGIC DISEASE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      CHRONIC SINUSITIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      OTHER CAUSES OF SOLID ORGAN EOSINOPHILIC DISEASE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H29\">",
"      Transplant rejection",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H30\">",
"      Irritation of serosal surfaces",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H31\">",
"      Hereditary eosinophilia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ID/5701\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ID/5701|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?13/50/14114\" title=\"picture 1\">",
"      Eosinophilic cellulitis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?24/10/24745?source=related_link\">",
"      Approach to the patient with eosinophilia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?27/2/27688?source=related_link\">",
"      Causes of pulmonary eosinophilia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?12/13/12505?source=related_link\">",
"      Clinical manifestations and diagnosis of acute renal allograft rejection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?29/24/30090?source=related_link\">",
"      Clinical manifestations, pathophysiology, and diagnosis of the hypereosinophilic syndromes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?36/28/37319?source=related_link\">",
"      Diagnosis of acute cellular rejection in liver transplantation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?19/1/19482?source=related_link\">",
"      Diagnosis of asthma in adolescents and adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?8/10/8360?source=related_link\">",
"      Eosinophilic fasciitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?42/43/43703?source=related_link\">",
"      Eosinophilic gastroenteritis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?5/18/5418?source=related_link\">",
"      Evaluation of subacute and chronic cough in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?8/36/8775?source=related_link\">",
"      Fungal rhinosinusitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?23/50/24359?source=related_link\">",
"      HIV-associated eosinophilic folliculitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?31/45/32474?source=related_link\">",
"      Pathogenesis, clinical manifestations, and diagnosis of eosinophilic esophagitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?28/53/29527?source=related_link\">",
"      Pleural fluid eosinophilia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?33/39/34418?source=related_link\">",
"      The significance of urinary eosinophils",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f39_37_40536="Esmolol: Drug information";
var content_f39_37_40536=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"14\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Esmolol: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"mobipreview.htm?3/27/3508?source=see_link\">",
"    see \"Esmolol: Patient drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?5/48/5895?source=see_link\">",
"    see \"Esmolol: Pediatric drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F166884\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Brevibloc",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F166885\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Brevibloc&reg;;",
"     </li>",
"     <li>",
"      Brevibloc&reg; Premixed",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F166918\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Antiarrhythmic Agent, Class II;",
"     </li>",
"     <li>",
"      Beta-Blocker, Beta-1 Selective",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F166889\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       U.S. labeling:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Intraoperative and postoperative tachycardia and/or hypertension:",
"     </b>",
"     I.V.:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <i>",
"      Immediate control:",
"     </i>",
"     Initial bolus: 1",
"     <b>",
"      mg",
"     </b>",
"     /kg over 30 seconds, followed by a 150 mcg/kg/minute infusion, if necessary. Adjust infusion rate as needed to maintain desired heart rate and/or blood pressure (up to 300 mcg/kg/minute)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <i>",
"      Gradual control:",
"     </i>",
"     Initial bolus: 0.5",
"     <b>",
"      mg",
"     </b>",
"     /kg over 1 minute, followed by a 50 mcg/kg/minute infusion for 4 minutes. Infusion may be continued at 50 mcg/kg/minute or, if the response is inadequate, titrated upward in 50 mcg/kg/minute increments (increased no more frequently than every 4 minutes) to a maximum of 300 mcg/kg/minute; may administer an optional loading dose equal to the initial bolus (0.5",
"     <b>",
"      mg",
"     </b>",
"     /kg over 1 minute) prior to each increase in infusion rate.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <i>",
"      For control of tachycardia,",
"     </i>",
"     doses &gt;200 mcg/kg/minute provide minimal additional effect.",
"     <i>",
"      For control of postoperative hypertension,",
"     </i>",
"     as many as one-third of patients may require higher doses (250-300 mcg/kg/minute) to control blood pressure; the safety of doses &gt;300 mcg/kg/minute has not been studied.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Supraventricular tachycardia (SVT) or noncompensatory sinus tachycardia:",
"     </b>",
"     I.V.: Loading dose (optional): 0.5",
"     <b>",
"      mg",
"     </b>",
"     /kg over 1 minute; follow with a 50 mcg/kg/minute infusion for 4 minutes; response to this initial infusion rate may be a rough indication of the responsiveness of the ventricular rate.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Infusion may be continued at 50 mcg/kg/minute or, if the response is inadequate, titrated upward in 50 mcg/kg/minute increments (increased no more frequently than every 4 minutes) to a maximum of 200 mcg/kg/minute.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     To achieve more rapid response, following the initial loading dose and 50 mcg/kg/minute infusion, rebolus with a second 0.5",
"     <b>",
"      mg",
"     </b>",
"     /kg loading dose over 1 minute, and increase the maintenance infusion to 100 mcg/kg/minute for 4 minutes. If necessary, a third (and final) 0.5",
"     <b>",
"      mg",
"     </b>",
"     /kg loading dose may be administered, prior to increasing to an infusion rate of 150 mcg/kg/minute. After 4 minutes of the 150 mcg/kg/minute infusion, the infusion rate may be increased to a maximum rate of 200 mcg/kg/minute (without a bolus dose).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <b>",
"      Note:",
"     </b>",
"     If a loading dose is not administered, a continuous infusion at a fixed dose reaches steady-state in ~30 minutes. In general, the usual effective dose is 50-200 mcg/kg/minute; doses as low as 25 mcg/kg/minute may be adequate. Maintenance infusions may be continued for up to 48 hours.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Acute coronary syndromes (when relative contraindications to beta-blockade exist; unlabeled use):",
"     </b>",
"     I.V.: 0.5",
"     <b>",
"      mg",
"     </b>",
"     /kg over 1 minute; follow with a 50 mcg/kg/minute infusion; if tolerated and response inadequate, may titrate upward in 50 mcg/kg/minute increments every 5-15 minutes to a maximum of 300 mcg/kg/minute (Mitchell, 2002); an additional bolus (0.5",
"     <b>",
"      mg",
"     </b>",
"     /kg over 1 minute) may be administered prior to each increase in infusion rate (Mooss, 1994)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Electroconvulsive therapy (unlabeled use):",
"     </b>",
"     I.V.:  1",
"     <b>",
"      mg",
"     </b>",
"     /kg administered 1 minute prior to induction of anesthesia (Weinger, 1991)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Intubation (unlabeled use):",
"     </b>",
"     I.V.: 1-2",
"     <b>",
"      mg",
"     </b>",
"     /kg given 1.5-3 minutes prior to intubation (Kindler, 1996)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Thyrotoxicosis or thyroid storm (unlabeled use):",
"     </b>",
"     I.V.: 50-100 mcg/kg/minute (Bahn, 2011)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Canadian labeling:",
"      </i>",
"     </b>",
"     <b>",
"      Note:",
"     </b>",
"     Not recommended for use &gt;24 hours.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:0em;text-align:justify;\">",
"     <b>",
"      Perioperative tachycardia and/or hypertension:",
"     </b>",
"     I.V.:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-top:0em;text-align:justify;\">",
"     Associated with intubation: Bolus: 1.5",
"     <b>",
"      mg",
"     </b>",
"     /kg (maximum dose: 100",
"     <b>",
"      mg",
"     </b>",
"     ) over 30 seconds given 1-2 minutes prior to intubation.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-top:0em;text-align:justify;\">",
"     Intraoperative/postoperative tachycardia and/or hypertension: Initial bolus: 1.5",
"     <b>",
"      mg",
"     </b>",
"     /kg (maximum dose: 100",
"     <b>",
"      mg",
"     </b>",
"     ) over 30 seconds, followed by 150 mcg/kg/minute infusion. Adjust infusion rate as needed to maintain desired heart rate or blood pressure (up to 300 mcg/kg/minute).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:0em;text-align:justify;\">",
"     <b>",
"      Atrial fibrillation/atrial flutter:",
"     </b>",
"     I.V.:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-top:0em;text-align:justify;\">",
"     Loading dose: 0.5",
"     <b>",
"      mg",
"     </b>",
"     /kg over 1 minute; follow with a 50 mcg/kg/minute infusion for 4 minutes; response to this initial infusion rate may be a rough indication of the responsiveness of the ventricular rate.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-top:0em;text-align:justify;\">",
"     Infusion may be continued at 50 mcg/kg/minute or, if the response is inadequate, rebolus with a second 0.5",
"     <b>",
"      mg",
"     </b>",
"     /kg loading dose over 1 minute, and increase the maintenance infusion to 100 mcg/kg/minute for 4 minutes. If necessary, repeat same procedure (ie, 0.5",
"     <b>",
"      mg",
"     </b>",
"     /kg loading dose and increase maintenance infusion by 50 mcg/kg/minute for 4 minutes) until target heart rate or safety end point (eg, hypotension) begins to occur then omit subsequent loading dose and decrease dosing increment of maintenance infusion to &le;25 mcg/kg/minute or alternatively, the manufacturer labeling suggests that the titration interval may be extended from 5 minutes to 10 minutes. If safety endpoints are exceeded discontinue infusion and when appropriate, resume infusion at reduced dose.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-top:0em;text-align:justify;\">",
"     <b>",
"      Note:",
"     </b>",
"     In general, the usual effective dose is 50-200 mcg/kg/minute; doses as low as 25 mcg/kg/minute may be adequate.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;\">",
"     <b>",
"      Guidelines for transfer to oral therapy (beta-blocker, calcium channel blocker):",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Infusion should be reduced by 50% thirty  minutes following the first dose of the alternative agent",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Manufacturer suggests following the second dose of the alternative drug, patient's response should be monitored and if control is adequate for the first hour, esmolol may be discontinued.",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F166890\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block dor drugH1Div\" id=\"F166891\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Renal Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No dosage adjustment necessary. Not removed by hemo- or peritoneal dialysis. Supplemental dose is not necessary.",
"    </p>",
"   </div>",
"   <div class=\"block doh drugH1Div\" id=\"F15837934\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Hepatic Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No dosage adjustment necessary.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F166862\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.  [DSC] = Discontinued product",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Infusion, premixed in NS, as hydrochloride [preservative free]:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Brevibloc: 2000 mg (100 mL) [20 mg/mL; double strength]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Brevibloc: 2500 mg (250 mL) [10 mg/mL]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Injection, solution, as hydrochloride [preservative free]: 10 mg/mL (10 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Brevibloc: 10 mg/mL (10 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Brevibloc: 20 mg/mL (5 mL [DSC]) [double strength]",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F166846\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes: Excludes infusion",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F166866\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Loading doses (eg, 0.5",
"     <b>",
"      mg",
"     </b>",
"     /kg) may be administered over 30 seconds to 1 minute depending on how urgent the need for effect. Infusion into small veins or through a butterfly catheter should be avoided (can cause thrombophlebitis). Medication port of premixed bags should be used to withdraw only the initial bolus, if necessary (not to be used for withdrawal of additional bolus doses).",
"    </p>",
"   </div>",
"   <div class=\"block uica drugH1Div\" id=\"F14471860\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Usual Infusion Concentrations: Adult",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Note:",
"     </b>",
"     Premixed solutions available.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      I.V. infusion:",
"     </b>",
"     2500 mg in 250 mL (concentration: 10,000",
"     <b>",
"      mcg",
"     </b>",
"     /mL)",
"     <b>",
"      or",
"     </b>",
"     2000 mg in 100 mL (concentration: 20,000",
"     <b>",
"      mcg",
"     </b>",
"     /mL) of D",
"     <sub>",
"      5",
"     </sub>",
"     W or NS",
"    </p>",
"   </div>",
"   <div class=\"block uicp drugH1Div\" id=\"F14471861\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Usual Infusion Concentrations: Pediatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Note:",
"     </b>",
"     Premixed solutions available.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      I.V. infusion:",
"     </b>",
"     10,000",
"     <b>",
"      mcg",
"     </b>",
"     /mL or 20,000",
"     <b>",
"      mcg",
"     </b>",
"     /mL",
"    </p>",
"   </div>",
"   <div class=\"block scp drugH1Div\" id=\"F166924\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Compatibility",
"    </span>",
"    <p style=\"text-indent:0em;margin-left:0em;display:inline\">",
"     Stable in D",
"     <sub>",
"      5",
"     </sub>",
"     LR, D",
"     <sub>",
"      5",
"     </sub>",
"     <sup>",
"      1",
"     </sup>",
"     /",
"     <sub>",
"      2",
"     </sub>",
"     NS, D",
"     <sub>",
"      5",
"     </sub>",
"     NS, D",
"     <sub>",
"      5",
"     </sub>",
"     W, D",
"     <sub>",
"      5",
"     </sub>",
"     R, D",
"     <sub>",
"      5",
"     </sub>",
"     W with KCl 40 mEq/L, LR,",
"     <sup>",
"      1",
"     </sup>",
"     /",
"     <sub>",
"      2",
"     </sub>",
"     NS, NS",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Y-site administration: Compatible:",
"     </b>",
"     Alcohol (ethyl), amikacin, aminophylline, amiodarone, ampicillin, atracurium, bivalirudin, butorphanol, calcium chloride, cefazolin, ceftazidime, chloramphenicol, cimetidine, cisatracurium, clindamycin, dexmedetomidine, diltiazem, dopamine, doripenem, enalaprilat, erythromycin lactobionate, famotidine, fenoldopam, fentanyl, gentamicin, heparin, hetastarch in lactated electrolyte injection (Hextend&reg;), hydrocortisone sodium succinate, insulin (regular), labetalol, linezolid, magnesium sulfate, methyldopate, metronidazole, micafungin, midazolam, morphine, nafcillin, nicardipine, nitroglycerin, nitroprusside, norepinephrine, pancuronium, penicillin G potassium, piperacillin, polymyxin B sulfate, potassium chloride, potassium phosphates, propofol, ranitidine, remifentanil, sodium acetate, streptomycin, sulfamethoxazole/trimethoprim, tacrolimus, terbutaline, tobramycin, vancomycin, vecuronium.",
"     <b>",
"      Incompatible:",
"     </b>",
"     Amphotericin B cholesteryl sulfate complex, furosemide, lansoprazole, pantoprazole, warfarin.",
"     <b>",
"      Variable (consult detailed reference):",
"     </b>",
"     Sodium bicarbonate",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F166865\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Treatment of supraventricular tachycardia (SVT) and atrial fibrillation/flutter (control ventricular rate); treatment of intraoperative and postoperative tachycardia and/or hypertension; treatment of noncompensatory sinus tachycardia",
"    </p>",
"   </div>",
"   <div class=\"block usu drugH1Div\" id=\"F1894140\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use - Unlabeled",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Children: SVT and postoperative hypertension",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Adults: Arrhythmia/rate control during acute coronary syndrome (eg, acute myocardial infarction, unstable angina), aortic dissection, intubation, thyroid storm, pheochromocytoma, electroconvulsive therapy",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F166926\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Esmolol may be confused with Osmitrol&reg;",
"      </p>",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Brevibloc&reg; may be confused with Brevital&reg;, Bumex&reg;, Buprenex&reg;",
"      </p>",
"     </div>",
"    </div>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      High alert medication:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       The Institute for Safe Medication Practices (ISMP) includes this medication among its list of drugs which have a heightened risk of causing significant patient harm when used in error.",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F166916\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     &gt;10%: Cardiovascular: Blood pressure decreased (20% to 50%), asymptomatic hypotension (dose related: 25%), symptomatic hypotension (dose related: 12%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     1% to 10%:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Cardiovascular: Peripheral ischemia (1%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Central nervous system: Dizziness (3%), somnolence (3%), confusion (2%), headache (2%), agitation (2%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Gastrointestinal: Nausea (7%), vomiting (1%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Local: Infusion site reaction (8%; including irritation, inflammation, and severe reactions associated with extravasation [eg, thrombophlebitis, necrosis, and blistering])",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     &lt;1% (Limited to important or life-threatening): Abdominal discomfort, abnormal thinking, angioedema, anorexia, anxiety, bradycardia, bronchospasm, cardiac arrest, constipation, coronary arteriospasm, decompensated heart failure, depression, dyspepsia, flushing, heart block, hyperkalemia, lightheadedness, pallor, paresthesia, psoriasis, renal tubular acidosis, seizure, severe bradycardia/asystole (rare), syncope, urinary retention, urticaria, xerostomia",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F166869\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;margin-left:0em;display:inline\">",
"     Hypersensitivity to esmolol or any component of the formulation; severe sinus bradycardia; heart block greater than first degree (except in patients with a functioning artificial ventricular pacemaker); sick sinus syndrome; cardiogenic shock; decompensated heart failure; I.V. administration of calcium channel blockers (eg, verapamil) in close proximity to esmolol (ie, while effects of other drug are still present); pulmonary hypertension",
"    </p>",
"    <p style=\"text-indent:0em;margin-left:0em;margin-top:2em;\">",
"     Canadian labeling: Additional contraindications (not in U.S. labeling): Patients requiring inotropic agents and/or vasopressors to maintain cardiac output and systolic blood pressure; hypotension; right ventricular failure secondary to pulmonary hypertension; untreated pheochromocytoma",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F166850\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concerns related to adverse effects:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Anaphylactic reactions: Use caution with history of severe anaphylaxis to allergens; patients taking beta-blockers may become more sensitive to repeated challenges. Treatment of anaphylaxis (eg, epinephrine) in patients taking beta-blockers may be ineffective or promote undesirable effects.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hyperkalemia: Esmolol has been associated with elevations in serum potassium and development of hyperkalemia especially in patients with risk factors (eg, renal impairment); monitor serum potassium during therapy.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hypotension: Can commonly occur; patients need close blood pressure monitoring. If an unacceptable drop in blood pressure occurs, reduction in dose or discontinuation may reverse hypotension (usually within 30 minutes).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Skin necrosis: Extravasation can lead to skin necrosis and sloughing; avoid infusions into small veins or through a butterfly catheter.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Disease-related concerns:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Bronchospastic disease: In general, patients with bronchospastic disease should not receive beta-blockers; however, esmolol, with B",
"     <sub>",
"      1",
"     </sub>",
"     selectivity, has been used cautiously with close monitoring.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Conduction abnormality: Can cause bradycardia including sinus pause, heart block, severe bradycardia, and cardiac arrest. Consider pre-existing conditions such as first degree AV block, sick sinus syndrome, or other conduction disorders before initiating; use is contraindicated in patients with sick sinus syndrome or second- or third-degree AV block (except in patients with a functioning artificial ventricular pacemaker).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Diabetes: Use with caution in patients with diabetes mellitus; may potentiate hypoglycemia and/or mask signs and symptoms.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Heart failure (HF): Use with caution in patients with compensated heart failure and monitor for a worsening of the condition. Use is contraindicated in patients with decompensated heart failure.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Myasthenia gravis: Use with caution in patients with myasthenia gravis.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Peripheral vascular disease (PVD) and Raynaud's disease: Can precipitate or aggravate symptoms of arterial insufficiency in patients with PVD and Raynaud's disease. Use with caution and monitor for progression of arterial obstruction.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Pheochromocytoma (untreated): Adequate alpha-blockade is required prior to use of any beta-blocker.  Canadian labeling contraindicates use in this patient population.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Renal impairment: Use with caution in patients with renal impairment; active metabolite retained.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Thyroid disease: May mask signs of hyperthyroidism (eg, tachycardia). If hyperthyroidism is suspected, carefully manage and monitor; abrupt withdrawal may exacerbate symptoms of hyperthyroidism or precipitate thyroid storm.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concurrent drug therapy issues:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Calcium channel blockers: Use with caution in patients on concurrent verapamil or diltiazem; bradycardia or heart block can occur (may be fatal). Use is contraindicated when I.V. calcium channel blockers have been administered in close proximity to esmolol (ie, while effects of other drug are still present).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Cardiac glycosides: Use with caution in patients receiving digoxin; bradycardia or heart block can occur.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Special populations:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Elderly: Bradycardia may be observed more frequently in elderly patients (&gt;65 years of age); dosage reductions may be necessary.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Other warnings/precautions:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Abrupt withdrawal: Beta-blocker therapy should not be withdrawn abruptly (particularly in patients with CAD), but gradually tapered to avoid acute tachycardia, hypertension, and/or ischemia. Severe exacerbation of angina, ventricular arrhythmias, and myocardial infarction (MI) have been reported following abrupt withdrawal of beta-blocker therapy. Temporary but prompt resumption of beta-blocker therapy may be indicated with worsening of angina or acute coronary insufficiency.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hypertension associated with hypothermia: Use esmolol with caution in patients with hypertension associated with hypothermia; monitor vital signs closely and titrate esmolol slowly.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hypovolemic patients: Avoid use in patients with hypovolemia; treat hypovolemia first, otherwise, use of esmolol may attenuate reflex tachycardia and further increase the risk of hypotension.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13299284\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F166855\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Acetylcholinesterase Inhibitors: May enhance the bradycardic effect of Beta-Blockers.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Alpha-/Beta-Agonists (Direct-Acting): Beta-Blockers may enhance the vasopressor effect of Alpha-/Beta-Agonists (Direct-Acting). Epinephrine used as a local anesthetic for dental procedures will not likely cause clinically relevant problems.  Management: Cardioselective beta-blockers and lower doses of epinephrine may confer a more limited risk. Patients who may require acute subcutaneous epinephrine (e.g., bee sting kits) should probably avoid beta blockers.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Dipivefrin.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Alpha1-Blockers: Beta-Blockers may enhance the orthostatic hypotensive effect of Alpha1-Blockers. The risk associated with ophthalmic products is probably less than systemic products.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Alpha2-Agonists: May enhance the AV-blocking effect of Beta-Blockers. Sinus node dysfunction may also be enhanced. Beta-Blockers may enhance the rebound hypertensive effect of Alpha2-Agonists. This effect can occur when the alpha",
"     <sub>",
"      2",
"     </sub>",
"     -agonist is abruptly withdrawn. Management: Closely monitor heart rate during treatment with a beta blocker and clonidine. Withdraw beta blockers several days before clonidine withdrawal when possible, and monitor blood pressure closely. Recommendations for other alpha2-agonists are unavailable.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Apraclonidine; Brimonidine.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Amifostine: Antihypertensives may enhance the hypotensive effect of Amifostine.  Management: When amifostine is used at chemotherapy doses, antihypertensive medications should be withheld for 24 hours prior to amifostine administration. If antihypertensive therapy can not be withheld, amifostine should not be administered.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Aminoquinolines (Antimalarial): May decrease the metabolism of Beta-Blockers.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Amiodarone: May enhance the bradycardic effect of Beta-Blockers. Possibly to the point of cardiac arrest. Amiodarone may increase the serum concentration of Beta-Blockers.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Anilidopiperidine Opioids: May enhance the bradycardic effect of Beta-Blockers. Anilidopiperidine Opioids may enhance the hypotensive effect of Beta-Blockers.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Antihypertensives: May enhance the hypotensive effect of other Antihypertensives.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Antipsychotic Agents (Phenothiazines): May enhance the hypotensive effect of Beta-Blockers. Beta-Blockers may decrease the metabolism of Antipsychotic Agents (Phenothiazines). Antipsychotic Agents (Phenothiazines) may decrease the metabolism of Beta-Blockers.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Barbiturates: May decrease the serum concentration of Beta-Blockers.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Beta2-Agonists: Beta-Blockers (Beta1 Selective) may diminish the bronchodilatory effect of Beta2-Agonists. Of particular concern with nonselective beta-blockers or higher doses of the beta1 selective beta-blockers.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Bupivacaine: Beta-Blockers may increase the serum concentration of Bupivacaine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Calcium Channel Blockers (Dihydropyridine): May enhance the hypotensive effect of Beta-Blockers. Bradycardia and signs of heart failure have also been reported.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Calcium Channel Blockers (Nondihydropyridine): May enhance the hypotensive effect of Beta-Blockers. Bradycardia and signs of heart failure have also been reported. Calcium Channel Blockers (Nondihydropyridine) may increase the serum concentration of Beta-Blockers.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Bepridil [Off Market].",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Cardiac Glycosides: Beta-Blockers may enhance the bradycardic effect of Cardiac Glycosides.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Cholinergic Agonists: Beta-Blockers may enhance the adverse/toxic effect of Cholinergic Agonists. Of particular concern are the potential for cardiac conduction abnormalities and bronchoconstriction.  Management: Administer these agents in combination with caution, and monitor for conduction disturbances.  Avoid methacholine with any beta blocker due to the potential for additive bronchoconstriction.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Diazoxide: May enhance the hypotensive effect of Antihypertensives.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Dipyridamole: May enhance the bradycardic effect of Beta-Blockers.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Disopyramide: May enhance the bradycardic effect of Beta-Blockers.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Dronedarone: May enhance the bradycardic effect of Beta-Blockers. Dronedarone may increase the serum concentration of Beta-Blockers. This likely applies only to those agents that are metabolized by CYP2D6. Management: Use lower initial beta-blocker doses; adequate tolerance of the combination, based on ECG findings, should be confirmed prior to any increase in beta-blocker dose.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ergot Derivatives: Beta-Blockers may enhance the vasoconstricting effect of Ergot Derivatives.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Fingolimod: Beta-Blockers may enhance the bradycardic effect of Fingolimod.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Floctafenine: May enhance the adverse/toxic effect of Beta-Blockers.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Herbs (Hypertensive Properties): May diminish the antihypertensive effect of Antihypertensives.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Herbs (Hypotensive Properties): May enhance the hypotensive effect of Antihypertensives.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Hypotensive Agents: May enhance the adverse/toxic effect of other Hypotensive Agents.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Insulin: Beta-Blockers may enhance the hypoglycemic effect of Insulin.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Lidocaine (Systemic): Beta-Blockers may increase the serum concentration of Lidocaine (Systemic).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Lidocaine (Topical): Beta-Blockers may increase the serum concentration of Lidocaine (Topical).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     MAO Inhibitors: May enhance the orthostatic hypotensive effect of Orthostatic Hypotension Producing Agents.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Mepivacaine: Beta-Blockers may increase the serum concentration of Mepivacaine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Methacholine: Beta-Blockers may enhance the adverse/toxic effect of Methacholine.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Methylphenidate: May diminish the antihypertensive effect of Antihypertensives.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Midodrine: Beta-Blockers may enhance the bradycardic effect of Midodrine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Nonsteroidal Anti-Inflammatory Agents: May diminish the antihypertensive effect of Beta-Blockers.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pentoxifylline: May enhance the hypotensive effect of Antihypertensives.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Phosphodiesterase 5 Inhibitors: May enhance the antihypertensive effect of Antihypertensives.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Propafenone: May increase the serum concentration of Beta-Blockers. Propafenone possesses some independent beta blocking activity.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Prostacyclin Analogues: May enhance the hypotensive effect of Antihypertensives.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     QuiNIDine: May decrease the metabolism of Beta-Blockers.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Reserpine: May enhance the hypotensive effect of Beta-Blockers.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Rifamycin Derivatives: May decrease the serum concentration of Beta-Blockers.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Rifabutin.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     RiTUXimab: Antihypertensives may enhance the hypotensive effect of RiTUXimab.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Sulfonylureas: Beta-Blockers may enhance the hypoglycemic effect of Sulfonylureas. Cardioselective beta-blockers (eg, acebutolol, atenolol, metoprolol, and penbutolol) may be safer than nonselective beta-blockers. All beta-blockers appear to mask tachycardia as an initial symptom of hypoglycemia. Ophthalmic beta-blockers are probably associated with lower risk than systemic agents.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Theophylline Derivatives: Beta-Blockers (Beta1 Selective) may diminish the bronchodilatory effect of Theophylline Derivatives.  Management: Monitor for reduced theophylline efficacy during concomitant use with any beta-blocker.  Beta-1 selective agents are less likely to antagonize theophylline than nonselective agents, but selectivity may be lost at higher doses.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Yohimbine: May diminish the antihypertensive effect of Antihypertensives.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F166858\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     C (",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F1894141\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Adverse events were observed in some animal reproduction studies. Esmolol has been shown to decrease fetal heart rate. Adverse fetal/neonatal events have also been observed with the chronic use of beta-blockers during pregnancy. Esmolol is a short-acting beta-blocker and not indicated for the chronic treatment of hypertension. Esmolol may be considered for the acute management of atrial fibrillation in pregnant women (Fuster, 2006). Esmolol has been evaluated for use during intubation as an agent to offset the exaggerated pressor response observed in pregnant women with hypertension undergoing surgery (Bansal, 2002).",
"    </p>",
"   </div>",
"   <div class=\"block lac drugH1Div\" id=\"F166894\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Lactation",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Excretion in breast milk unknown/not recommended",
"    </p>",
"   </div>",
"   <div class=\"block brc drugH1Div\" id=\"F10533918\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Breast-Feeding Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     It is not known if esmolol is excreted into breast milk. Due to the potential for serious adverse reactions in the nursing infant, the manufacturer recommends a decision be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of treatment to the mother. The short half-life and the fact that it is not intended for chronic use should limit any potential exposure to the nursing infant.",
"    </p>",
"   </div>",
"   <div class=\"block fee drugH1Div\" id=\"F16323135\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pricing: U.S. (Medi-Span&reg;)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Solution",
"     </b>",
"     (Brevibloc in NaCl Intravenous)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     10-5.9 mg/mL (250 mL): $191.97",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     20-4.1 mg/mL (100 mL): $201.12",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Solution",
"     </b>",
"     (Brevibloc Intravenous)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     10 mg/mL (10 mL): $23.27",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Solution",
"     </b>",
"     (Esmolol HCl Intravenous)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     10 mg/mL (10 mL): $17.04",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F166860\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Blood pressure, MAP, heart rate, continuous ECG, respiratory rate, I.V. site; serum potassium (especially with renal impairment)",
"    </p>",
"   </div>",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F166871\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Ai Luo (CL);",
"     </li>",
"     <li>",
"      Breviblo (PK);",
"     </li>",
"     <li>",
"      Brevibloc (AR, AT, AU, BE, BR, CH, CZ, DK, ES, FI, FR, GB, GR, HK, HN, HU, IE, IT, KP, MX, NL, NO, NZ, PL, SE, TH, TR, TW, UY);",
"     </li>",
"     <li>",
"      Escord (IN)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F166849\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Class II antiarrhythmic: Competitively blocks response to beta",
"     <sub>",
"      1",
"     </sub>",
"     -adrenergic stimulation with little or no effect of beta",
"     <sub>",
"      2",
"     </sub>",
"     -receptors except at high doses, no intrinsic sympathomimetic activity, no membrane stabilizing activity",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F166868\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Onset of action: Beta-blockade: I.V.: 2-10 minutes (quickest when loading doses are administered)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Duration of hemodynamic effects: 10-30 minutes; prolonged following higher cumulative doses, extended duration of use",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Distribution: V",
"     <sub>",
"      d",
"     </sub>",
"     : Esmolol: ~3.4 L/kg; Acid metabolite: ~0.4 L/kg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Protein binding: Esmolol: 55%; Acid metabolite: 10%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Metabolism: In blood by red blood cell esterases; forms acid metabolite (negligible activity; produces no clinically important effects) and methanol (does not achieve concentrations associated with methanol toxicity)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Half-life elimination: Adults: Esmolol: 9 minutes; Acid metabolite: 3.7 hours; elimination of metabolite decreases with end-stage renal disease",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Excretion: Urine (~73% to 88% as acid metabolite, &lt;2% unchanged drug)",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Angaran DM, Schultz NJ, and Tschida VH, \"Esmolol Hydrochloride: An Ultrashort-Acting, Beta-Adrenergic Blocking Agent,\"",
"      <i>",
"       Clin Pharm",
"      </i>",
"      , 1986, 5(4):288-303.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?39/37/40536/abstract-text/2871961/pubmed\" id=\"2871961\" target=\"_blank\">",
"        2871961",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Anderson JL, Adams CD, Antman EM, et al, \"ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction) Developed in Collaboration With the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons Endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine,\"",
"      <i>",
"       J Am Coll Cardiol",
"      </i>",
"      , 2007, 50(7):e1-e157.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?39/37/40536/abstract-text/17692738/pubmed\" id=\"17692738\" target=\"_blank\">",
"        17692738",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Antman EM, Anbe SC, Alpert JS, et al, \"ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction - Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1999 Guidelines for the Management of Patients With Acute Myocardial Infarction),\"",
"      <i>",
"       Circulation",
"      </i>",
"      , 2004, 110(5):588-636.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?39/37/40536/abstract-text/15289388/pubmed\" id=\"15289388\" target=\"_blank\">",
"        15289388",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Bahn RS (Chair), Burch HB, Cooper DS, et al, &ldquo;Hyperthyroidism and Other Causes of Thyrotoxicosis: Management Guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists,&rdquo;",
"      <i>",
"       Thyroid",
"      </i>",
"      , 2011, 21(6):593-646.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?39/37/40536/abstract-text/ 21510801/pubmed\" id=\" 21510801\" target=\"_blank\">",
"        21510801",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Bansal S and Pawar M, \"Haemodynamic Responses to Laryngoscopy and Intubation in Patients With Pregnancy-Induced Hypertension: Effect of Intravenous Esmolol With or Without Lidocaine,\"",
"      <i>",
"       Int J Obstet Anesth",
"      </i>",
"      , 2002, 11(1):4-8.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?39/37/40536/abstract-text/15321570/pubmed\" id=\"15321570\" target=\"_blank\">",
"        15321570",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Blomstr&ouml;m-Lundqvist C, Scheinman MM, Aliot EM, et al, &ldquo;ACC/AHA/ESC Guidelines for the Management of Patients With Supraventricular Arrhythmias--Executive Summary. A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Supraventricular Arrhythmias),&rdquo;",
"      <i>",
"       Circulation",
"      </i>",
"      , 2003, 108(15):1871-909.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?39/37/40536/abstract-text/14557344/pubmed\" id=\"14557344\" target=\"_blank\">",
"        14557344",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Brunette DD and Rothong C, \"Emergency Department Management of Thyrotoxic Crisis With Esmolol,\"",
"      <i>",
"       Am J Emerg Med",
"      </i>",
"      , 1991, 9(3):232-4.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?39/37/40536/abstract-text/1673341/pubmed\" id=\"1673341\" target=\"_blank\">",
"        1673341",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Chobanian AV, Bakris GL, Black HR, et al, \"The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 Report,\"",
"      <i>",
"       JAMA",
"      </i>",
"      , 2003, 289(19):2560-71.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?39/37/40536/abstract-text/12748199/pubmed\" id=\"12748199\" target=\"_blank\">",
"        12748199",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Cuneo BF, Zales VR, Blahunka PC, et al, \"Pharmacodynamics and Pharmacokinetics of Esmolol, A Short-Acting Beta-Blocking Agent in Children,\"",
"      <i>",
"       Pediatr Cardiol",
"      </i>",
"      , 1994, 15(6):296-301.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?39/37/40536/abstract-text/7838803/pubmed\" id=\"7838803\" target=\"_blank\">",
"        7838803",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Erstad BL and Barletta JF, \"Treatment of Hypertension in the Perioperative Patient,\"",
"      <i>",
"       Ann Pharmacother",
"      </i>",
"      , 2000, 34(1):66-79.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?39/37/40536/abstract-text/10669188/pubmed\" id=\"10669188\" target=\"_blank\">",
"        10669188",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Fihn SD, Gardin JM, Abrams J, et al, &ldquo;2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons,&rdquo;",
"      <i>",
"       Circulation",
"      </i>",
"      , 2012, 126(25):3097-137.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?39/37/40536/abstract-text/23166211/pubmed\" id=\"23166211\" target=\"_blank\">",
"        23166211",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Fuster V, Ryden LE, Cannom DS, et al, \"ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation-Executive Summary. A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation). Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society,\"",
"      <i>",
"       J Am Coll Cardiol",
"      </i>",
"      , 2006, 48(4):854-906.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?39/37/40536/abstract-text/16904574 /pubmed\" id=\"16904574 \" target=\"_blank\">",
"        16904574",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Gorczynski RJ, \"Basic Pharmacology of Esmolol,\"",
"      <i>",
"       Am J Cardiol",
"      </i>",
"      , 1985, 56(11):3F-13F.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?39/37/40536/abstract-text/2864846/pubmed\" id=\"2864846\" target=\"_blank\">",
"        2864846",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Gray RJ, \"Managing Critically Ill Patients With Esmolol: An Ultra-Short Acting Beta-Adrenergic Blocker,\"",
"      <i>",
"       Chest",
"      </i>",
"      , 1988, 93(2):398-403.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?39/37/40536/abstract-text/2892647/pubmed\" id=\"2892647\" target=\"_blank\">",
"        2892647",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Hillis LD, Smith PK, Anderson JL, et al, &ldquo;2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines,&rdquo;",
"      <i>",
"       Circulation",
"      </i>",
"      , 2011, 124(23):2610-42.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?39/37/40536/abstract-text/22064600/pubmed\" id=\"22064600\" target=\"_blank\">",
"        22064600",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Kindler CH, Schumacher PG, Schneider MC, et al, \"Effects of Intravenous Lidocaine and/or Esmolol on Hemodynamic Responses to Laryngoscopy and Intubation: A Double-Blind, Controlled Clinical Trial,\"",
"      <i>",
"       J Clin Anesth",
"      </i>",
"      , 1996, 8(6):491-6.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?39/37/40536/abstract-text/8872690/pubmed\" id=\"8872690\" target=\"_blank\">",
"        8872690",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Lang DM, \"Anaphylactoid and Anaphylactic Reactions. Hazards of Beta-Blockers,\"",
"      <i>",
"       Drug Saf",
"      </i>",
"      , 1995, 12(5):299-304.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?39/37/40536/abstract-text/7669259/pubmed\" id=\"7669259\" target=\"_blank\">",
"        7669259",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Lowenthal DT, Porter RS, Saris SD, et al, \"Clinical Pharmacology, Pharmacodynamics and Interactions With Esmolol,\"",
"      <i>",
"       Am J Cardiol",
"      </i>",
"      , 1985, 56(11):14F-18F.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?39/37/40536/abstract-text/2864843/pubmed\" id=\"2864843\" target=\"_blank\">",
"        2864843",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Luyt D, Dance M, Litmanovich H, et al, \"Esmolol in the Treatment of Severe Tachycardia in Neonatal Tetanus,\"",
"      <i>",
"       Anaesth Intensive Care",
"      </i>",
"      , 1994, 22(3):303-4.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?39/37/40536/abstract-text/7916178/pubmed\" id=\"7916178\" target=\"_blank\">",
"        7916178",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Miller A and White S, \"Survival Following Massive Intravenous Esmolol Overdose,\"",
"      <i>",
"       Clin Toxicol",
"      </i>",
"      , 1995, 33(5):490-1.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Mitchell RG, Stoddard MF, Ben-Yehuda O, et al, \"Esmolol in Acute Ischemic Syndromes,\"",
"      <i>",
"       Am Heart J",
"      </i>",
"      , 2002, 144(5):E9.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?39/37/40536/abstract-text/12422138/pubmed\" id=\"12422138\" target=\"_blank\">",
"        12422138",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Mooss AN, Hilleman DE, Mohiuddin SM, et al, \"Safety of Esmolol in Patients With Acute Myocardial Infarction Treated With Thrombolytic Therapy Who Had Relative Contraindications to Beta-Blocker Therapy,\"",
"      <i>",
"       Ann Pharmacother",
"      </i>",
"      , 1994, 28(6):701-3.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?39/37/40536/abstract-text/7919552/pubmed\" id=\"7919552\" target=\"_blank\">",
"        7919552",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents, \"The Fourth Report on the Diagnosis, Evaluation, and Treatment of High Blood Pressure in Children and Adolescents,\"",
"      <i>",
"       Pediatrics",
"      </i>",
"      , 2004, 114(2 Suppl):555-76.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?39/37/40536/abstract-text/15286277/pubmed\" id=\"15286277\" target=\"_blank\">",
"        15286277",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Phillips MS, &ldquo;Standardizing I.V. Infusion Concentrations: National Survey Results,&rdquo;",
"      <i>",
"       Am J Health Syst Pharm",
"      </i>",
"      , 2011, 68(22):2176-82.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?39/37/40536/abstract-text/22058104/pubmed\" id=\"22058104\" target=\"_blank\">",
"        22058104",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Skanes AC, Healey JS, Cairns JA, et al, &ldquo;Focused 2012 Update of the Canadian Cardiovascular Society Atrial Fibrillation Guidelines: Recommendations for Stroke Prevention and Rate/Rhythm Control,&rdquo;",
"      <i>",
"       Can J Cardiol",
"      </i>",
"      , 2012, 28(2):125-36.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?39/37/40536/abstract-text/22433576/pubmed\" id=\"22433576\" target=\"_blank\">",
"        22433576",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Trippel DL, Wiest DB, and Gillette PC, \"Cardiovascular and Antiarrhythmic Effects of Esmolol in Children,\"",
"      <i>",
"       J Pediatr",
"      </i>",
"      , 1991, 119(1):142-7.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?39/37/40536/abstract-text/1676729/pubmed\" id=\"1676729\" target=\"_blank\">",
"        1676729",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Vincent RN, Click LA, Williams HM, et al, \"Esmolol As an Adjunct in the Treatment of Systemic Hypertension After Operative Repair of Coarctation of the Aorta,\"",
"      <i>",
"       Am J Cardiol",
"      </i>",
"      , 1990, 65(13):941-3.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?39/37/40536/abstract-text/1969710/pubmed\" id=\"1969710\" target=\"_blank\">",
"        1969710",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Wann SL, Curtis AB, January CT, et al, \"2011 ACCF/AHA/HRS Focused Update on the Management of Patients With Atrial Fibrillation (Updating the 2006 Guideline): A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines,\"",
"      <i>",
"       Circulation",
"      </i>",
"      , 2011, 123 (1):104-23.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?39/37/40536/abstract-text/21173346/pubmed\" id=\"21173346\" target=\"_blank\">",
"        21173346",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Weinger MB, Partridge BL, Hauger R, et al, \"Prevention of the Cardiovascular and Neuroendocrine Response to Electroconvulsive Therapy: I. Effectiveness of Pretreatment Regimens on Hemodynamics,\"",
"      <i>",
"       Anesth Analg",
"      </i>",
"      , 1991, 73(5):556-62.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?39/37/40536/abstract-text/1952135/pubmed\" id=\"1952135\" target=\"_blank\">",
"        1952135",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Wiest DB, \"Esmolol: A Review of Its Therapeutic Efficacy and Pharmacokinetic Characteristics,\"",
"      <i>",
"       Clin Pharmacokinet",
"      </i>",
"      , 1995, 28(3):190-202.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?39/37/40536/abstract-text/7758250/pubmed\" id=\"7758250\" target=\"_blank\">",
"        7758250",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Wiest DB, Garner SS, and Childress LM, \"Stability of Esmolol Hydrochloride in 5% Dextrose Injection,\"",
"      <i>",
"       Am J Health Syst Pharm",
"      </i>",
"      , 1995, 52(7):716-8.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?39/37/40536/abstract-text/7627740/pubmed\" id=\"7627740\" target=\"_blank\">",
"        7627740",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Wiest DB, Trippel DL, Gillette PC, et al, \"Pharmacokinetics of Esmolol in Children,\"",
"      <i>",
"       Clin Pharmacol Ther",
"      </i>",
"      , 1991, 49(6):618-23.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?39/37/40536/abstract-text/1676357/pubmed\" id=\"1676357\" target=\"_blank\">",
"        1676357",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 9420 Version 46.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-61.234.146.186-FF4A722CD6-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_37_40536=[""].join("\n");
var outline_f39_37_40536=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F166884\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F166885\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F166918\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F166889\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F166890\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F166891\">",
"      Dosing: Renal Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F15837934\">",
"      Dosing: Hepatic Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F166862\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F166846\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F166866\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14471860\">",
"      Usual Infusion Concentrations: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14471861\">",
"      Usual Infusion Concentrations: Pediatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F166924\">",
"      Compatibility",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F166865\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1894140\">",
"      Use - Unlabeled",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F166926\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F166916\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F166869\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F166850\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13299284\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F166855\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F166858\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1894141\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F166894\">",
"      Lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10533918\">",
"      Breast-Feeding Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F16323135\">",
"      Pricing: U.S. (Medi-Span&reg;)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F166860\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F166871\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F166849\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F166868\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9420\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9420|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?3/27/3508?source=related_link\">",
"      Esmolol: Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?5/48/5895?source=related_link\">",
"      Esmolol: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f39_37_40537="BM findings in myeloproliferative HES";
var content_f39_37_40537=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ALLRG%2F87634&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ALLRG%2F87634&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 633px\">",
"   <div class=\"ttl\">",
"    Bone marrow findings in myeloproliferative variants of hypereosinophilic syndrome (HES)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 613px; height: 361px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The bone marrow biopsy sections presented are from two representative patients with hypereosinophilic syndrome&nbsp;with (A-C) and without (D-F) elevated serum tryptase levels stained with hematoxylin and eosin (A, D), antitryptase antibody (B, E), and antireticulin antibody (C, F). Although the bone marrow biopsy specimens from both patients show a dramatic increase in eosinophils and myeloid precursors (A, D), only the specimen from the patient with elevated serum tryptase shows marked hypercellularity (A), atypical spindle-shaped mast cells (B), and reticulin fibrosis (C).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     This research was originally published in Blood. Klion AD, Noel P, Akin C, et al. Elevated serum tryptase levels identify a subset of patients with a myeloproliferative variant of idiopathic hypereosinophilic syndrome associated with tissue fibrosis, poor prognosis, and imatinib responsiveness. Blood 2003; 101:4660. Copyright &copy; 2003 American Society of Hematology.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_37_40537=[""].join("\n");
var outline_f39_37_40537=null;
var title_f39_37_40538="Basophilic stippling";
var content_f39_37_40538=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F71989%7EHEME%2F73790%7EHEME%2F60588&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F71989%7EHEME%2F73790%7EHEME%2F60588&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic2\" style=\"width: 1040px;\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Basophilic stippling of red cells in lead poisoning",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 347px; height: 283px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Peripheral blood smear shows basophilic stippling in several red cells from a patient with lead poisoning. The granules represent ribosomal precipitates. A similar picture can be seen in a number of other conditions including thalassemia, megaloblastic anemia, sickle cell anemia, and sideroblastic anemia.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Carola von Kapff, SH (ASCP).",
"    </div>",
"   </div>",
"  </div>",
"  <div class=\"figure\" style=\"width: 450px\">",
"   <div class=\"ttl\">",
"    Normal peripheral blood smear",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 393px; height: 257px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    High power view of a normal peripheral blood smear. Several platelets (black arrows) and a normal lymphocyte (blue arrow) can also be seen. The red cells are of relatively uniform size and shape. The diameter of the normal red cell should approximate that of the nucleus of the small lymphocyte; central pallor (red arrow) should equal one-third of its diameter.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Carola von Kapff, SH (ASCP).",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic2\" style=\"width: 1040px;\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Peripheral smear in Heinz body hemolytic anemia showing Heinz bodies and bite cells",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 389px; height: 270px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Split screen view of a peripheral smear from a patient with Heinz body hemolytic anemia. Left panel: red cells with characteristic bite-like deformity (arrows). Right panel: Heinz body preparation which reveals the denatured hemoglobin precipitates.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Carola von Kapff, SH (ASCP).",
"    </div>",
"   </div>",
"  </div>",
"  <div class=\"figure\" style=\"width: 450px\">",
"   <div class=\"ttl\">",
"    Normal peripheral blood smear",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 393px; height: 257px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    High power view of a normal peripheral blood smear. Several platelets (black arrows) and a normal lymphocyte (blue arrow) can also be seen. The red cells are of relatively uniform size and shape. The diameter of the normal red cell should approximate that of the nucleus of the small lymphocyte; central pallor (red arrow) should equal one-third of its diameter.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Carola von Kapff, SH (ASCP).",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic2\" style=\"width: 1040px;\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Howell-Jolly bodies following splenectomy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 238px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This peripheral blood smear shows two red blood cells (RBC) that contain Howell-Jolly bodies (black arrows). Howell-Jolly bodies are remnants of RBC nuclei that are normally removed by the spleen. Thus, they are seen in patients who have undergone splenectomy (as in this case) or who have functional asplenia (eg, from sickle cell disease). Target cells (blue arrows) are another consequence of splenectomy.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Carola von Kapff, SH (ASCP).",
"    </div>",
"   </div>",
"  </div>",
"  <div class=\"figure\" style=\"width: 450px\">",
"   <div class=\"ttl\">",
"    Normal peripheral blood smear",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 393px; height: 257px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    High power view of a normal peripheral blood smear. Several platelets (black arrows) and a normal lymphocyte (blue arrow) can also be seen. The red cells are of relatively uniform size and shape. The diameter of the normal red cell should approximate that of the nucleus of the small lymphocyte; central pallor (red arrow) should equal one-third of its diameter.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Carola von Kapff, SH (ASCP).",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_37_40538=[""].join("\n");
var outline_f39_37_40538=null;
var title_f39_37_40539="Initiation of pressure-cycled NPPV in NM disease";
var content_f39_37_40539=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F51437&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=7\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F51437&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=7\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Protocol for initiation of noninvasive positive pressure ventilation using pressure-cycled ventilator",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td>",
"       1. Choose appropriately monitored location.",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       2. Direct patient to sit in bed or chair at &gt;30 angle. Ensure patient comfort.",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       3. Obtain baseline vital signs, arterial blood gas, and oximetry, as clinically indicated.",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       4. Select and fit interface (nasal or oronasal mask).",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       5. Apply headgear; avoid excessive strap tension (one or two fingers under strap).",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       6. Select ventilator.",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       7. Connect interface to ventilator tubing and turn on ventilator.",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       8. For pressure-cycled ventilator, start with low pressure in spontaneously triggered mode; pressure limited: inspiratory pressure (IPAP) 8 to 10 cm H2O; expiratory pressure (EPAP) 4 to 5 cm H2O. A back up rate of 2 breaths per minute below the patient's spontaneous nocturnal rate.",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       9. Gradually increase inspiratory pressure by 2.5 cm H2O increments, as tolerated, to achieve alleviation of dyspnea, decreased respiratory rate, increased tidal volume (if being monitored), and good patient-ventilator synchrony.",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       10. Check for air leaks, readjust straps as needed. Add chin strap, if oral air leak noted.",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       11. Add heated humidification, as indicated.",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       12. Provide encouragement, reassurance, and frequent checks and adjustments as needed.",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       13. Monitor vital signs and oximetry during trial; obtain occasional blood gases (within 1 to 2 hours) and then as needed.",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_37_40539=[""].join("\n");
var outline_f39_37_40539=null;
var title_f39_37_40540="Mediastinal mesenchymal tumors";
var content_f39_37_40540=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F70025&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F70025&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Mesenchymal tumors of the mediastinum",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Tumors of lymph vessels",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Lymphangioma",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Lymphangiomatosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Lymphangiomyoma",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Tumors of blood",
"vessel origin",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hemangioma",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hemangioendothelioma",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hemangiomatosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Epithelioid hemangioendothelioma",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Angiosarcoma",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Tumors of pericyte",
"origin",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hemangiopericytoma",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Tumors and",
"tumor-like fibro-histiocytic lesions",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Fibromatosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Fibrosarcoma",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Malignant fibrous histiocytoma",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Tumors of adipose",
"tissue",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Lipoma",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Lipomatosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Lipoblastomatosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Liposarcoma",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Tumors of muscle",
"origin",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Rhabdomyoma",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Rhabdomyosarcoma",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Leiomyoma",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Leiomyosarcoma",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Tumors of",
"pluripotential mesenchyme",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Benign mesenchymoma",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Malignant mesenchymoma",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Synovial sarcoma",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Tumors of skeletal",
"tissues",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Chondroma",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Osteogenic sarcoma",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Chondrosarcoma",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Other tumors and",
"tumor-like conditions",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Solitary fibrous tumor",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Myxoma",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Meningioma",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Chordoma",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Granular cell tumor",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Extramedullary hematopoiesis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Histiocytosis X",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Amyloid tumor",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Marchevsky, AM, Kaneko. M. Surgical Pathology of the Mediastinum, 2nd ed, Raven Press, New York, 1992.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_37_40540=[""].join("\n");
var outline_f39_37_40540=null;
var title_f39_37_40541="Etiology protein losing enterop";
var content_f39_37_40541=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F53419&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F53419&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Causes of protein-losing gastroenteropathy",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\" class=\"container\">",
"     <tbody>",
"      <tr>",
"       <td class=\"container\">",
"        <table cellspacing=\"0\">",
"         <tbody>",
"          <tr>",
"           <td class=\"subtitle1_single\">",
"            Inflammatory exudation due to mucosal erosions or ulcerations",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"sublist1_start\">",
"            Inflammatory bowel disease",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"sublist1\">",
"            Crohn's disease",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"sublist1\">",
"            Ulcerative colitis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"sublist1_start\">",
"            Gastrointestinal malignancy",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"sublist1\">",
"            Gastric cancer",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"sublist1\">",
"            Lymphoma",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"sublist1\">",
"            Kaposi's sarcoma",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"sublist1\">",
"            Alpha chain disease",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Pseudomembranous colitis due to C. difficile",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Erosive gastritis and multiple gastric ulcers",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            NSAID enteropathy",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Post-chemotherapy",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Cap polyposis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Graft-versus-host disease",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"subtitle1_single\">",
"            Intestinal loss of lymphatic fluid due to lymphatic obstruction",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Primary intestinal lymphangiectasia",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"sublist1_start\">",
"            Right-sided heart failure",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"sublist1\">",
"            Heart failure",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"sublist1\">",
"            Constrictive pericarditis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"sublist1\">",
"            Congenital heart diseases",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"sublist1\">",
"            Fontan procedure for single ventricle",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Retroperitoneal lymph node enlargement (eg, due to chemotherapy, infection, or toxin exposure)",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Cirrhosis/portal hypertensive gastropathy",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Hepatic venous outflow obstruction",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Enteric-lymphatic fistula",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Mesenteric venous thrombosis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Mesenteric tuberculosis or sarcoidosis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Sclerosing mesenteritis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Neoplasia involving the mesenteric lymph nodes or lymphatics",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Chronic pancreatitis with pseudocysts",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Crohn's disease",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Whipple's disease",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Thoracic duct obstruction",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Congenital malformations of lymphatics",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Retroperitoneal fibrosis",
"           </td>",
"          </tr>",
"         </tbody>",
"        </table>",
"       </td>",
"       <td class=\"container\">",
"        <table cellspacing=\"0\">",
"         <tbody>",
"          <tr>",
"           <td class=\"subtitle1_single\">",
"            Increased permeability due to mucosal disease without erosions or ulcerations",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Celiac disease",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Tropical sprue",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"sublist1_start\">",
"            Giant hypertrophic gastritis (Menetrier's disease)",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"sublist1\">",
"            Possible relation to Helicobacter pylori infection",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Lymphocytic gastritis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Secretory hypertrophic gastropathy",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Amyloidosis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"sublist1_start\">",
"            Infections",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"sublist1\">",
"            Bacterial overgrowth",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"sublist1\">",
"            Acute viral infection",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"sublist1\">",
"            Parasitic infection",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"sublist1\">",
"            Whipple's disease",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"sublist1_start\">",
"            Rheumatic diseases",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"sublist1\">",
"            Systemic lupus erythematosus",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"sublist1\">",
"            Rheumatoid arthritis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"sublist1\">",
"            Mixed connective tissue disease",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"sublist1\">",
"            Intestinal vasculitis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Allergic gastroenteropathy",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Eosinophilic gastroenteritis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Collagenous colitis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Congenital disorders of glycosylation",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Congenital enterocyte heparin sulfate deficiency",
"           </td>",
"          </tr>",
"         </tbody>",
"        </table>",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_37_40541=[""].join("\n");
var outline_f39_37_40541=null;
var title_f39_37_40542="Scleromalacia perforans";
var content_f39_37_40542=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RHEUM%2F78096&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RHEUM%2F78096&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Scleromalacia perforans",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 329px; height: 216px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Scleromalacia perforans in a patient with rheumatoid arthritis. There are areas of significant collagen breakdown in the scleral wall with little to no associated redness or vascular engorgement.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of M Reza Dana, MD, MPH.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_37_40542=[""].join("\n");
var outline_f39_37_40542=null;
var title_f39_37_40543="Radiohumeral range of motion";
var content_f39_37_40543=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F51261&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F51261&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Range of motion of the radiohumeral joint",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 403px; height: 353px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Passive supination and pronation are compared side to side while palpating the radial head. Loss of full supination or pronation suggests a previous fracture or dislocation of the elbow, or osteonecrosis.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Bruce C Anderson, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_37_40543=[""].join("\n");
var outline_f39_37_40543=null;
